<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Reverse pharmacology - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"fd023406-0048-4cac-be44-92de1ff2a04b","wgCSPNonce":false,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Reverse_pharmacology","wgTitle":"Reverse pharmacology","wgCurRevisionId":1067674048,"wgRevisionId":1067674048,"wgArticleId":35290643,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1: long volume value","Articles with short description","Short description matches Wikidata","All articles with unsourced statements","Articles with unsourced statements from December 2021","Drug discovery"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext",
"wgRelevantPageName":"Reverse_pharmacology","wgRelevantArticleId":35290643,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"skin":"vector","wgFlaggedRevsParams":{"tags":{"status":{"levels":-1}}},"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":true,"nearby":true,"watchlist":true,"tagline":false},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":50000,"wgNoticeProject":"wikipedia","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":10,"wgULSCurrentAutonym":"English","wgEditSubmitButtonLabelPublish":true,"wgCentralAuthMobileDomain":false,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":true,"wgWikibaseItemId":"Q7318256","wgGENewcomerTasksGuidanceEnabled":true,"wgGEAskQuestionEnabled":false,"wgGELinkRecommendationsFrontendEnabled":false};RLSTATE={"ext.globalCssJs.user.styles":
"ready","site.styles":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","ext.tmh.thumbnail.styles":"ready","skins.vector.styles.legacy":"ready","jquery.makeCollapsible.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.wikimediaBadges":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","mw.MediaWikiPlayer.loader","mw.PopUpMediaTransform","mw.TMHGalleryHook.js","site","mediawiki.page.ready","jquery.makeCollapsible","mediawiki.toc","skins.vector.legacy.js","ext.gadget.ReferenceTooltips","ext.gadget.charinsert","ext.gadget.extra-toolbar-buttons","ext.gadget.refToolbar","ext.gadget.switcher","mmv.head","mmv.bootstrap.autostart","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.cx.eventlogging.campaigns","ext.centralNotice.geoIP",
"ext.centralNotice.startUp","ext.centralauth.centralautologin","ext.popups","ext.uls.compactlinks","ext.uls.interface","ext.growthExperiments.SuggestedEditSession"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1i9g4",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.tmh.thumbnail.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cskins.vector.styles.legacy%7Cwikibase.client.init&amp;only=styles&amp;skin=vector"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector"></script>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector"/>
<meta name="generator" content="MediaWiki 1.38.0-wmf.19"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta name="format-detection" content="telephone=no"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/8/82/Forward_and_reverse_pharmacology.jpg"/>
<meta property="og:image:width" content="1200"/>
<meta property="og:image:height" content="979"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/8/82/Forward_and_reverse_pharmacology.jpg"/>
<meta property="og:image:width" content="800"/>
<meta property="og:image:height" content="652"/>
<meta property="og:image:width" content="640"/>
<meta property="og:image:height" content="522"/>
<meta property="og:title" content="Reverse pharmacology - Wikipedia"/>
<meta property="og:type" content="website"/>
<link rel="preconnect" href="//upload.wikimedia.org"/>
<link rel="alternate" media="only screen and (max-width: 720px)" href="//en.m.wikipedia.org/wiki/Reverse_pharmacology"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Reverse_pharmacology&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="https://creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Reverse_pharmacology"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Reverse_pharmacology rootpage-Reverse_pharmacology skin-vector action-view skin-vector-legacy"><div id="mw-page-base" class="noprint"></div>
<div id="mw-head-base" class="noprint"></div>
<div id="content" class="mw-body" role="main">
	<a id="top"></a>
	<div id="siteNotice"><!-- CentralNotice --></div>
	<div class="mw-indicators">
	</div>
	<h1 id="firstHeading" class="firstHeading mw-first-heading">Reverse pharmacology</h1>
	<div id="bodyContent" class="vector-body">
		<div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div>
		<div id="contentSub"></div>
		<div id="contentSub2"></div>
		
		<div id="jump-to-nav"></div>
		<a class="mw-jump-link" href="#mw-head">Jump to navigation</a>
		<a class="mw-jump-link" href="#searchInput">Jump to search</a>
		<div id="mw-content-text" class="mw-body-content mw-content-ltr" lang="en" dir="ltr"><div class="mw-parser-output"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Drug discovery by identifying protein targets</div>
<style data-mw-deduplicate="TemplateStyles:r1033289096">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}</style><div role="note" class="hatnote navigation-not-searchable">This article is about hypothesis driven drug discovery. For Ashok Vaidya's clinical trial method, see <a href="/wiki/Classical_pharmacology#Application_to_Ayurvedic_drugs" title="Classical pharmacology">Classical pharmacology §&#160;Application to Ayurvedic drugs</a>.</div>
<div class="thumb tright"><div class="thumbinner" style="width:402px;"><a href="/wiki/File:Forward_and_reverse_pharmacology.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/82/Forward_and_reverse_pharmacology.jpg/400px-Forward_and_reverse_pharmacology.jpg" decoding="async" width="400" height="326" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/82/Forward_and_reverse_pharmacology.jpg/600px-Forward_and_reverse_pharmacology.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/8/82/Forward_and_reverse_pharmacology.jpg 2x" data-file-width="602" data-file-height="491" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Forward_and_reverse_pharmacology.jpg" class="internal" title="Enlarge"></a></div><a href="/wiki/Classical_pharmacology" title="Classical pharmacology">Forward</a> and reverse pharmacology approaches in drug discovery</div></div></div>
<p>In the field of <a href="/wiki/Drug_discovery" title="Drug discovery">drug discovery</a>, <b>reverse pharmacology</b> <sup id="cite_ref-pmid11589663_1-0" class="reference"><a href="#cite_note-pmid11589663-1">&#91;1&#93;</a></sup><sup id="cite_ref-pmid18403648_2-0" class="reference"><a href="#cite_note-pmid18403648-2">&#91;2&#93;</a></sup><sup id="cite_ref-isbn0-12-369521-X_3-0" class="reference"><a href="#cite_note-isbn0-12-369521-X-3">&#91;3&#93;</a></sup> also known as <b>target-based drug discovery</b> (TDD),<sup id="cite_ref-pmid22409666_4-0" class="reference"><a href="#cite_note-pmid22409666-4">&#91;4&#93;</a></sup> a hypothesis is first made that modulation of the activity of a specific <a href="/wiki/Biological_target" title="Biological target">protein target</a> will have beneficial therapeutic effects.  <a href="/wiki/High-throughput_screening" title="High-throughput screening">Screening</a> of <a href="/wiki/Chemical_library" title="Chemical library">chemical libraries</a> of <a href="/wiki/Small_molecule" title="Small molecule">small molecules</a> is then used to identify compounds that bind with high affinity to the target.  The hits from these screens are then used as starting points for drug discovery.  This method became popular after the <a href="/wiki/Human_Genome_Project" title="Human Genome Project">sequencing</a> of the <a href="/wiki/Human_genome" title="Human genome">human genome</a> which allowed rapid cloning and synthesis of large quantities of purified proteins.  This method is the most widely used in drug discovery today.<sup id="cite_ref-Swinney_2011_5-0" class="reference"><a href="#cite_note-Swinney_2011-5">&#91;5&#93;</a></sup> Differently than the classical (<a href="/wiki/Classical_pharmacology" title="Classical pharmacology">forward</a>) pharmacology, with the reverse pharmacology approach <i>in vivo</i> efficacy of identified active (<a href="/wiki/Lead_compound" title="Lead compound">lead</a>) compounds is usually performed in the final <a href="/wiki/Drug_discovery" title="Drug discovery">drug discovery</a> stages.
</p><p>Reverse pharmacology or target-based pharmacology, is a process of <a href="/wiki/Drug_development" title="Drug development">drug development</a> where identity of a molecular target (<a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptor</a>, <a href="/wiki/Enzyme" title="Enzyme">enzyme</a>, <a href="/wiki/Protein" title="Protein">protein</a>, etc) drives compound screening. Classical pharmacology involves determining the functional activity of a compound through <a href="/wiki/In_vitro" title="In vitro">in vitro</a> and <a href="/wiki/In_vivo" title="In vivo">in vivo</a> models. Once the activity of compound is found, the compounds ligands are identified, purified, and synthesized and go through biological screening assays. The most selective and potent drug is then further screened for toxicity and efficacy. Classical pharmacology can be time consuming and expensive. Reverse pharmacology was first established in the 70's by Dir Ram Nath Chopra and Gannath Sen.<sup id="cite_ref-Blondeau_1682–1696_6-0" class="reference"><a href="#cite_note-Blondeau_1682–1696-6">&#91;6&#93;</a></sup> Reverse pharmacology, in contrast, takes potential drug compounds, designed specifically to targets (receptors, enzyme, proteins, etc) involved in disorders or diseases. Binding assays are used to identify the molecular target. The compound then undergoes animal functional studies to show the desired effect. Compounds identified through reverse pharmacology are thought to increase efficacy.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">&#91;<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (December 2021)">citation needed</span></a></i>&#93;</sup> The goal of reverse pharmacology is to utilize disease pathology in order to identify specific and targetable elements that novel compounds can be modeled from.
</p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Reverse_vaccinology"><span class="tocnumber">1</span> <span class="toctext">Reverse vaccinology</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Applications_of_reverse_vaccinology"><span class="tocnumber">1.1</span> <span class="toctext">Applications of reverse vaccinology</span></a>
<ul>
<li class="toclevel-3 tocsection-3"><a href="#Group_B_Menigococcus"><span class="tocnumber">1.1.1</span> <span class="toctext">Group B Menigococcus</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-4"><a href="#Limits_to_reverse_vaccinology"><span class="tocnumber">1.2</span> <span class="toctext">Limits to reverse vaccinology</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Reverse_vaccinology_tools_and_applications"><span class="tocnumber">1.3</span> <span class="toctext">Reverse vaccinology tools and applications</span></a>
<ul>
<li class="toclevel-3 tocsection-6"><a href="#NERVE"><span class="tocnumber">1.3.1</span> <span class="toctext">NERVE</span></a></li>
<li class="toclevel-3 tocsection-7"><a href="#Vaxign"><span class="tocnumber">1.3.2</span> <span class="toctext">Vaxign</span></a></li>
<li class="toclevel-3 tocsection-8"><a href="#EpiVax_and_iVAX_Toolkit"><span class="tocnumber">1.3.3</span> <span class="toctext">EpiVax and iVAX Toolkit</span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-9"><a href="#Reverse_pharmacognosy"><span class="tocnumber">2</span> <span class="toctext">Reverse pharmacognosy</span></a>
<ul>
<li class="toclevel-2 tocsection-10"><a href="#Summary"><span class="tocnumber">2.1</span> <span class="toctext">Summary</span></a>
<ul>
<li class="toclevel-3 tocsection-11"><a href="#Selection_of_Molecules"><span class="tocnumber">2.1.1</span> <span class="toctext">Selection of Molecules</span></a></li>
<li class="toclevel-3 tocsection-12"><a href="#Target_Identification_and_Discovery_of_Activities"><span class="tocnumber">2.1.2</span> <span class="toctext">Target Identification and Discovery of Activities</span></a></li>
<li class="toclevel-3 tocsection-13"><a href="#Biological_Assays_and_Organism_Associated_Activities"><span class="tocnumber">2.1.3</span> <span class="toctext">Biological Assays and Organism Associated Activities</span></a></li>
<li class="toclevel-3 tocsection-14"><a href="#Activity_Optimization"><span class="tocnumber">2.1.4</span> <span class="toctext">Activity Optimization</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-15"><a href="#Reverse_pharmacognosy_tools_and_applications"><span class="tocnumber">2.2</span> <span class="toctext">Reverse pharmacognosy tools and applications</span></a>
<ul>
<li class="toclevel-3 tocsection-16"><a href="#Greenpharma&#39;s_reverse_pharmacognosy_platform"><span class="tocnumber">2.2.1</span> <span class="toctext">Greenpharma's reverse pharmacognosy platform</span></a></li>
<li class="toclevel-3 tocsection-17"><a href="#Selnergy"><span class="tocnumber">2.2.2</span> <span class="toctext">Selnergy</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-18"><a href="#Potential_use_in_traditional_systems_of_medicine"><span class="tocnumber">2.3</span> <span class="toctext">Potential use in traditional systems of medicine</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-19"><a href="#Target_identification_and_characterization"><span class="tocnumber">3</span> <span class="toctext">Target identification and characterization</span></a>
<ul>
<li class="toclevel-2 tocsection-20"><a href="#High_throughput_screening"><span class="tocnumber">3.1</span> <span class="toctext">High throughput screening</span></a></li>
<li class="toclevel-2 tocsection-21"><a href="#Molecular_docking"><span class="tocnumber">3.2</span> <span class="toctext">Molecular docking</span></a></li>
<li class="toclevel-2 tocsection-22"><a href="#Molecular_Docking_Programs"><span class="tocnumber">3.3</span> <span class="toctext">Molecular Docking Programs</span></a>
<ul>
<li class="toclevel-3 tocsection-23"><a href="#DOCK"><span class="tocnumber">3.3.1</span> <span class="toctext">DOCK</span></a></li>
<li class="toclevel-3 tocsection-24"><a href="#MORDOR"><span class="tocnumber">3.3.2</span> <span class="toctext">MORDOR</span></a></li>
<li class="toclevel-3 tocsection-25"><a href="#AMBER"><span class="tocnumber">3.3.3</span> <span class="toctext">AMBER</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-26"><a href="#Reverse_docking"><span class="tocnumber">3.4</span> <span class="toctext">Reverse docking</span></a></li>
<li class="toclevel-2 tocsection-27"><a href="#Reverse_docking_programs"><span class="tocnumber">3.5</span> <span class="toctext">Reverse docking programs</span></a>
<ul>
<li class="toclevel-3 tocsection-28"><a href="#INVDOCK"><span class="tocnumber">3.5.1</span> <span class="toctext">INVDOCK</span></a></li>
<li class="toclevel-3 tocsection-29"><a href="#TarFisDock"><span class="tocnumber">3.5.2</span> <span class="toctext">TarFisDock</span></a></li>
<li class="toclevel-3 tocsection-30"><a href="#idTarget"><span class="tocnumber">3.5.3</span> <span class="toctext">idTarget</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-31"><a href="#Challenges_with_molecular_docking"><span class="tocnumber">3.6</span> <span class="toctext">Challenges with molecular docking</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-32"><a href="#Orphan_receptors"><span class="tocnumber">4</span> <span class="toctext">Orphan receptors</span></a>
<ul>
<li class="toclevel-2 tocsection-33"><a href="#Functional_assays_for_identifying_orphaned_GPCRs"><span class="tocnumber">4.1</span> <span class="toctext">Functional assays for identifying orphaned GPCRs</span></a>
<ul>
<li class="toclevel-3 tocsection-34"><a href="#Bioluminescent_energy_transfer_(BRET)"><span class="tocnumber">4.1.1</span> <span class="toctext">Bioluminescent energy transfer (BRET)</span></a></li>
<li class="toclevel-3 tocsection-35"><a href="#Adaption_of_pheromone_receptor_pathway"><span class="tocnumber">4.1.2</span> <span class="toctext">Adaption of pheromone receptor pathway</span></a></li>
<li class="toclevel-3 tocsection-36"><a href="#Bead-based_screening_with_Xenopus_melanophores"><span class="tocnumber">4.1.3</span> <span class="toctext">Bead-based screening with <i>Xenopus melanophores</i></span></a></li>
<li class="toclevel-3 tocsection-37"><a href="#Pharmacochaperone_screening_assay"><span class="tocnumber">4.1.4</span> <span class="toctext">Pharmacochaperone screening assay</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-38"><a href="#Identification_of_orexin"><span class="tocnumber">4.2</span> <span class="toctext">Identification of orexin</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-39"><a href="#See_also"><span class="tocnumber">5</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-40"><a href="#References"><span class="tocnumber">6</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h2><span class="mw-headline" id="Reverse_vaccinology">Reverse vaccinology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=1" title="Edit section: Reverse vaccinology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:294px;"><a href="/wiki/File:Reverse_Vaccinology_Flowchart.pdf" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1f/Reverse_Vaccinology_Flowchart.pdf/page1-292px-Reverse_Vaccinology_Flowchart.pdf.jpg" decoding="async" width="292" height="378" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1f/Reverse_Vaccinology_Flowchart.pdf/page1-438px-Reverse_Vaccinology_Flowchart.pdf.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1f/Reverse_Vaccinology_Flowchart.pdf/page1-584px-Reverse_Vaccinology_Flowchart.pdf.jpg 2x" data-file-width="1275" data-file-height="1650" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Reverse_Vaccinology_Flowchart.pdf" class="internal" title="Enlarge"></a></div>Flowchart of reverse vaccinology</div></div></div>
<p>A subcategory of reverse pharmacology, reverse <a href="/wiki/Vaccinology" class="mw-redirect" title="Vaccinology">vaccinology</a> is a computational approach for discovery of <a href="/wiki/Vaccine" title="Vaccine">vaccines</a> through utilization of the <a href="/wiki/Genome" title="Genome">genome</a>. Traditionally vaccines have been developed through the isolation, inactivation, and re-injection of viruses. Conventional vaccinology is both time consuming and limited to antigens that are able to be purified for testing.<sup id="cite_ref-:4_7-0" class="reference"><a href="#cite_note-:4-7">&#91;7&#93;</a></sup>
</p><p><a href="/wiki/Rino_Rappuoli" title="Rino Rappuoli">Rino Rappuoli</a> and the <a href="/wiki/J._Craig_Venter_Institute" title="J. Craig Venter Institute">J. Craig Venter Institute</a>  used reverse vaccinology to develop a vaccine against Serogroup B meningococcus.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8">&#91;8&#93;</a></sup> Vaccines utilizing reverse vaccinology tend to have better selectivity; reducing side effects. These vaccines can increase immunity of multiple strains by incorporating multiple proteins.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9">&#91;9&#93;</a></sup>
</p><p>The reverse vaccinology approach uses the genome sequence of the pathogen itself. Researchers are able to determine the all of the protein antigens that a pathogen can express. Reverse vaccinology begins with the genomic sequence of the pathogen and computer prediction of candidates for vaccines. Scientists use computational analysis to obtain the genome of the virus which allows for the determination of proteins that are secreted during viral infection. Through the secreted proteins, scientists are then able to identify and purify the virus, allowing further research consisting of immunizing laboratory animals. The elicited immune response is studied and are used for identification of a vaccine.<sup id="cite_ref-:0_10-0" class="reference"><a href="#cite_note-:0-10">&#91;10&#93;</a></sup> Conventional vaccinology differs from reverse vaccinology in that the proteins purified from a cultured pathogen are used as candidates for a vaccine.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11">&#91;11&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Applications_of_reverse_vaccinology">Applications of reverse vaccinology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=2" title="Edit section: Applications of reverse vaccinology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Diseases such as Malaria, Tuberculosis, and Syphilis have fully been sequences and lists of all possible genes can be accessed.
</p>
<h4><span class="mw-headline" id="Group_B_Menigococcus">Group B Menigococcus</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=3" title="Edit section: Group B Menigococcus">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Group B Menigococcus is the first application of reverse vaccinology. The polysaccharide that was used to develop early vaccines was poorly immunogenic and caused autoimmunity. A vaccine needed to be made against the surface exposed proteins and were able to be folded within the outer membrane. Rino Rappuoli and the J. Craig Venter Institute were able to screen DNA fragments for genes that coded surface exposed and exported proteins. These proteins were purified and used to immunize mice. 25 of 85 surface proteins were shown to produce antibodies. These proteins were the basis of the vaccine against Group B Menigococcus.<sup id="cite_ref-:4_7-1" class="reference"><a href="#cite_note-:4-7">&#91;7&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Limits_to_reverse_vaccinology">Limits to reverse vaccinology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=4" title="Edit section: Limits to reverse vaccinology">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The goal of a vaccine is protective immunity against a pathogen. Vaccinology relies on the availability of databases that can predict whether the candidates can provide protective immunity against the pathogen. Lack of knowledge surrounding vaccine immunology and effects of mutations down the line, it is hard to predict protective immunity. Another limitation of reverse vaccinology is the identification antigens that are not proteins.
</p>
<h3><span class="mw-headline" id="Reverse_vaccinology_tools_and_applications">Reverse vaccinology tools and applications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=5" title="Edit section: Reverse vaccinology tools and applications">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>More than 4000 viral genomes have been identified.<sup id="cite_ref-:0_10-1" class="reference"><a href="#cite_note-:0-10">&#91;10&#93;</a></sup> Reverse vaccinology heavily uses bioinformatics to analyze and obtain vast viral genomes.
</p>
<h4><span class="mw-headline" id="NERVE">NERVE</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=6" title="Edit section: NERVE">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><a rel="nofollow" class="external text" href="http://www.bio.unipd.it/molbinfo/">New Enhanced Reverse Vaccinology Environment (NERVE)</a> is a reverse vaccinology software that imports pathogen protein sequences and predicts biological sequences. This software predicts the sub-cellular localization, adhesion probability, <a href="/wiki/Topology" title="Topology">topology</a>, human sequence similarity, and conservation of these proteins. NERVE uses four criteria to predict potential vaccine candidates: proteins that do not lie in the <a href="/wiki/Cytoplasm" title="Cytoplasm">cytoplasm</a>, proteins with 2 or less transmembrane helices, a probability of adhesion &gt;0.46 and proteins that have low similarity to human proteins.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12">&#91;12&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Vaxign">Vaxign</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=7" title="Edit section: Vaxign">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><a rel="nofollow" class="external text" href="http://www.violinet.org/vaxign2">Vaxign</a> was the first vaccine design program for reverse vaccinology and vaccine development. It uses both external and internal tools and programs to predict vaccine targets. Users input amino acids from proteins are genomes and is able to predict subcellular localization, <a href="/wiki/Transmembrane_domain" title="Transmembrane domain">transmembrane domains</a>, adhesion probability, protein conservation among genomes, exclusion of nonpathogenic strains, comparison of proteins and host, prediction of binding to <a href="/wiki/MHC_class_I" title="MHC class I">MHC class I and II</a>, and analysis of the protein function.
</p><p><sup id="cite_ref-13" class="reference"><a href="#cite_note-13">&#91;13&#93;</a></sup>
</p><p>Vaxign has two broad methods of vaccine design: "General" and "Specific" Methods. Within "General Methods" users can further choose to search under Vaxign Query or Dynamic Vaxign Analysis. Vaxign Query allows the users to search precomputed results for around 300 genomes. Users are able to choose genomes for vaccine targets based on desired parameters or protein sequences. The Dynamic Vaxign Analysis has users input protein sequences and set up parameters. This analytical tool uses the automatic Vaxign pipeline.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14">&#91;14&#93;</a></sup> This pipeline includes predictions for sublocation, adhesion, epitope binding to MCH class I and class II, and similarity to the host genome sequences.
</p><p>Under the "Specific Methods", users have the option of Vaxitop and Vaxign-ML. Vaxitop makes predictions on vaccine epitopes based on reverse vaccinology.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup> Vaxitop specifically predicts the binding to MHC Class and II. Vaxitop allows users to perform a genome whide query for different MHC host species. Vaxign-ML uses machine learning to produce vaccine candidates.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16">&#91;16&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="EpiVax_and_iVAX_Toolkit">EpiVax and iVAX Toolkit</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=8" title="Edit section: EpiVax and iVAX Toolkit">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><a href="/wiki/EpiVax" title="EpiVax">EpiVax</a> is a private company, based in Providence, RI, that uses <a href="/wiki/In_silico" title="In silico"><i>in silico</i></a>, <a href="/wiki/In_vitro" title="In vitro"><i>in vitro</i></a>, and <a href="/wiki/In_vivo" title="In vivo"><i>in vivo</i></a> applications to design new vaccines. EpiVax created the iVAX Toolkit, an <i>in silico</i> platform that allows users to identify and predict epitopes for vaccine development.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17">&#91;17&#93;</a></sup>
</p><p>iVAX is a computational vaccine design program that encompasses epitope mapping, antigen selection, and immunogen design. This toolkit uses immunoinformatics algorithms to identify candidate antigens and select for conserved T cell epitopes, eliminating epitopes from regulatory T cells. iVAX has a collection of tools such as Conservatrix, EpiMatrix, ClustiMer, and EpiAssembler.  Vaccine design begins with searching for MHC class I and II ligands. EpiMatrix performs this initial search by parsing and evaluating each input sequence for binding efficacy. The program removes low quality binders to curate personalized predictions. These <a href="/wiki/Epitope" title="Epitope">epitopes</a> can be further analyzed for clusters using ClustiMer. Users can find cross-strain, conserved epitopes using Conservatrix.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18">&#91;18&#93;</a></sup> This toolkit integrates <i>in silico</i> and <a href="/wiki/Ex_vivo" title="Ex vivo"><i>ex vivo</i></a>/<i>in vitro</i> technology to allow vaccine developers to access toxicity, efficacy, and performance of vaccines.
</p>
<div class="thumb tright"><div class="thumbinner" style="width:342px;"><a href="/wiki/File:Classical_and_reverse_pharmacognosy.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Classical_and_reverse_pharmacognosy.png/340px-Classical_and_reverse_pharmacognosy.png" decoding="async" width="340" height="190" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Classical_and_reverse_pharmacognosy.png/510px-Classical_and_reverse_pharmacognosy.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/36/Classical_and_reverse_pharmacognosy.png/680px-Classical_and_reverse_pharmacognosy.png 2x" data-file-width="2304" data-file-height="1290" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Classical_and_reverse_pharmacognosy.png" class="internal" title="Enlarge"></a></div>Classical and reverse pharmacognosy</div></div></div>
<h2><span class="mw-headline" id="Reverse_pharmacognosy">Reverse pharmacognosy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=9" title="Edit section: Reverse pharmacognosy">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/Pharmacognosy" title="Pharmacognosy">Pharmacognosy</a> is a multi disciplinary science that studies the applications of <a href="/wiki/Natural_product" title="Natural product">natural compounds</a>. Pharmacognosy is derived from the Greek <i>pharmakon</i>, meaning drug or recipe, and <i>gnosis, meaning knowledge.</i> Pharmacognosy is not limited to the natural compound application in therapeutics, but can also include cosmetics, agricultures, and dyes. Conventional pharmacognosy utilizes traditional knowledge of living organisms to find new bioactive molecules. Conventional pharmacognosy begins with using <a href="/wiki/Ethnomedicine" title="Ethnomedicine">ethopharmacological</a> data to select plants. Once these plants are selected, extracts of these plants are made and tested in biological assays. If an extract is biologically active, the extracts are fractionated and retested multiple times to identify the molecules responsible for the activity.
</p><p>Reverse Pharmacognosy attempts to use the knowledge generated from pharmacognosy to introduce new therapeutic activities of natural products. Molecules are first selected based on criteria (eg. structure, chemical family, activity). Next, the selected compounds are used to identify potential targets. Compounds can have a variety of different targets in metabolic pathways. This information gives insight on potential off-target effects and synergetic applications. "Inverse screening" involves identifying new properties for the selected compounds. Predicted interaction partners can be validated using in vitro binding assays or virtual screenings.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19">&#91;19&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Summary">Summary</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=10" title="Edit section: Summary">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<h4><span class="mw-headline" id="Selection_of_Molecules">Selection of Molecules</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=11" title="Edit section: Selection of Molecules">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The first step in reverse pharmacognosy is the selection of natural compounds. Criteria can be applied depending on the compound is proposed for: structural criteria, molecules from the same chemical family, compounds with drug-like properties, etc. Natural product databases can also be helpful for compound selection.
</p>
<h4><span class="mw-headline" id="Target_Identification_and_Discovery_of_Activities">Target Identification and Discovery of Activities</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=12" title="Edit section: Target Identification and Discovery of Activities">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The second step in reverse pharmacognosy is identifying the target which will bind to the selected compounds. There can be many targets that a ligand can interact with, these interactions can illicit either negative or favorable effects, so it is important to identify all possible interactions. Researchers at this step commonly use "inverse screening" where they screen proteins which will potentially bind their molecules. Predictions about selectivity and synergy can be calculated which cannot be achieved through classical docking.
</p>
<h4><span class="mw-headline" id="Biological_Assays_and_Organism_Associated_Activities">Biological Assays and Organism Associated Activities</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=13" title="Edit section: Biological Assays and Organism Associated Activities">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>While virtual screening are fairly accurate at predicting the biological activities of compounds and their proteins, these interactions can only be confirmed through in vitro biological assays. in vivo models of biological activities are needed to confirm that there is the same biological properties from the in vitro experiments.
</p>
<h4><span class="mw-headline" id="Activity_Optimization">Activity Optimization</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=14" title="Edit section: Activity Optimization">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Derivatives of natural products may be more potent, less toxic, more accessible from the compounds that were originally probed. Database of active extracts and metabolites can assist with this optimization.<sup id="cite_ref-Blondeau_1682–1696_6-1" class="reference"><a href="#cite_note-Blondeau_1682–1696-6">&#91;6&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Reverse_pharmacognosy_tools_and_applications">Reverse pharmacognosy tools and applications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=15" title="Edit section: Reverse pharmacognosy tools and applications">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Both <a href="/wiki/Cheminformatics" title="Cheminformatics">chemoinformatics</a> and inverse screening tools and target databases utilize reverse pharmacognosy.
</p><p>&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;
</p>
<table class="wikitable">
<caption>List of Databases for Natural Products
</caption>
<tbody><tr>
<th>Database Name
</th>
<th>Information
</th>
<th>Website
</th></tr>
<tr>
<td>Dr. Duke's Database
</td>
<td>Contains 50,000 entries on plants, chemicals, biological activities, syndrome, ethnobotany plants, and ethnobotany use
</td>
<td><a rel="nofollow" class="external autonumber" href="https://phytochem.nal.usda.gov/phytochem/search/list">[1]</a>
</td></tr>
<tr>
<td>ChemNetBase
</td>
<td>Collection of Interactive Databases and Dictionaries:
<p>-CRC Handbook of Chemistry and Physics
</p><p>-Combined Chemical Dictionary
</p><p>-Dictionary of Natural Products
</p><p>Dictionary of Organic Compounds
</p><p>-Dictionary of Drugs
</p><p>-Dictionary of Inorganic and Organometallic Compounds
</p><p>-Dictionary of Commonly Cited Compounds
</p><p>-Dictionary of Marine Natural Products
</p><p>-Dictionary of Food Compounds
</p><p>-Polymers: A Property Database
</p><p>-Propertied of Organic Compounds
</p>
</td>
<td><a rel="nofollow" class="external autonumber" href="https://www.chemnetbase.com/faces/search/SimpleSearch.xhtml">[2]</a>
</td></tr>
<tr>
<td>Napralert
</td>
<td>Relational database of natural products. Contains enthnomedical, pharmacological, and biochemical information on natural products
</td>
<td><a rel="nofollow" class="external autonumber" href="https://napralert.org/">[3]</a>
</td></tr>
<tr>
<td>Plants for a Future (PFAF)
</td>
<td>Contains the edible and medicinal uses of 7000+ plant.
</td>
<td><a rel="nofollow" class="external autonumber" href="https://pfaf.org/user/Default.aspx">[4]</a>
</td></tr>
<tr>
<td>Supernatural
</td>
<td>Contains 325,000+ natural products and their structures and physiochemical properties.
</td>
<td><a rel="nofollow" class="external autonumber" href="http://bioinf-applied.charite.de/supernatural_new/">[5]</a>
</td></tr></tbody></table>
<h4><span id="Greenpharma.27s_reverse_pharmacognosy_platform"></span><span class="mw-headline" id="Greenpharma's_reverse_pharmacognosy_platform">Greenpharma's reverse pharmacognosy platform</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=16" title="Edit section: Greenpharma&#039;s reverse pharmacognosy platform">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Greenpharma is a French R&amp;D company created in 2000 who supplies tailored products and services in the life sciences. They focus on natural substances and their platform consists of five components: <a href="/wiki/Analytical_chemistry" title="Analytical chemistry">analytical chemistry</a>, lab scale extractions, chemoinformatics, <a href="/wiki/Chemical_synthesis" title="Chemical synthesis">organic/bio synthesis</a>, and cosmetic formulations. Greenpharma offers three compound libraries for reverse pharmacognosy needs: <a rel="nofollow" class="external text" href="https://www.greenpharma.com/products/compound-librairies/">Greenpharma Natural Compound Library (GPNCL)</a>, <a rel="nofollow" class="external text" href="https://www.greenpharma.com/products/compound-librairies/">Greenpharma Ligand Library (LIGENDO)</a>, and <a rel="nofollow" class="external text" href="https://www.greenpharma.com/products/compound-librairies/">Greenpharma Plant Extract Library (GPEL)</a>.<sup id="cite_ref-:1_20-0" class="reference"><a href="#cite_note-:1-20">&#91;20&#93;</a></sup>
</p><p>The GPNCL is a collection of 150,000 natural compound structures for lead discovery. This library also has access to 30 million compounds from <a rel="nofollow" class="external text" href="http://www.ambinter.com/">Ambinter</a>. This library does not include amino acids, peptides, nucleic acids, or long fatty acid chains. They also have continuous stock of compounds at &gt;90% purity. The GPNCL provides the physico-chemical properties and phytochemistry of each of their compounds for researchers.<sup id="cite_ref-:1_20-1" class="reference"><a href="#cite_note-:1-20">&#91;20&#93;</a></sup>
</p><p>LIGENDO is a library source of natural, pure compounds for <a href="/wiki/Chemogenomics" title="Chemogenomics">chemogenomics</a> and biological pathway hopping. This library is composed of 400 human <a href="/wiki/Endogeny_(biology)" title="Endogeny (biology)">endogenous</a> ligands. Compounds are given in microplates of 80 and data is supplied in the database with compound name, structure, implied <a href="/wiki/Metabolic_pathway" title="Metabolic pathway">metabolic pathway</a>, physico-chemical properties, and protein partners.<sup id="cite_ref-:1_20-2" class="reference"><a href="#cite_note-:1-20">&#91;20&#93;</a></sup>
</p><p>GPEL is a plant extract library that combines botany, pharmacology, and pharmacognosy to present a wide range of possible extracts. The library is suitable for a high throughput screening which 80 extracts on each microplate for 20 plants. Greenpharma provides 4 different polarity solvent fractions. Information on the plant family, genus, species, and organ data is also provided.<sup id="cite_ref-:1_20-3" class="reference"><a href="#cite_note-:1-20">&#91;20&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Selnergy">Selnergy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=17" title="Edit section: Selnergy">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Selnergy is a virtual high throughput screening platform that allows users to explore interactions chemogenomics. It contains a database of 10,000 protein structures, sectioned by their biological properties. This platforms allows for in silico profiling of ligand and ligand-protein interactions. It allows the user to predict the selectivity and synergy between candidate compounds and their protein targets.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">&#91;21&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Potential_use_in_traditional_systems_of_medicine">Potential use in traditional systems of medicine</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=18" title="Edit section: Potential use in traditional systems of medicine">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Current drug discovery entails the identification of drug targets in disease pathology, large iterations of chemical compounds to discover drug candidates and performing biological assays to test for toxicity, potency, and efficacy. This traditional approach is  often considered costly and time consuming. Much of the world relies on traditional systems of medicine (TSM): Ayurveda, traditional Chinese medicine (TCM), etc. While these therapies are popular in non-western countries, their evidence of therapeutic benefits are seen as incomplete in western societies. Reverse pharmacology began as a way to study Ayurvedic plants chemically and clinically. The issue with studying Ayurvedic plants is that there was no defined approach in quantifying its benefits. The study of their herbal therapies can be investigated using reverse pharmacology.
</p>
<h2><span class="mw-headline" id="Target_identification_and_characterization">Target identification and characterization</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=19" title="Edit section: Target identification and characterization">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Proteins that are thought to be critical in pathogenesis are identified. These protein structures and their predicted function can be analyzed through bioinformatics. This enables the identification of candidate ligands. Receptor/ ligand interactions are often identified through high throughput screenings.<sup id="cite_ref-22" class="reference"><a href="#cite_note-22">&#91;22&#93;</a></sup>
</p>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:High-throughput_screening.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2e/High-throughput_screening.jpg/220px-High-throughput_screening.jpg" decoding="async" width="220" height="158" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2e/High-throughput_screening.jpg/330px-High-throughput_screening.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2e/High-throughput_screening.jpg/440px-High-throughput_screening.jpg 2x" data-file-width="2121" data-file-height="1520" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:High-throughput_screening.jpg" class="internal" title="Enlarge"></a></div>High-throughput screening</div></div></div>
<h3><span class="mw-headline" id="High_throughput_screening">High throughput screening</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=20" title="Edit section: High throughput screening">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/High-throughput_screening" title="High-throughput screening">High throughput screening</a> is method in drug discovery that allows scientists to conduct pharmacological tests. In regards to reverse pharmacology, this process is utilized for the  identification of compounds involved in a pathophysiology pathway.
</p>
<div class="thumb tright"><div class="thumbinner" style="width:274px;"><a href="/wiki/File:Docking_representation_2.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/97/Docking_representation_2.png/272px-Docking_representation_2.png" decoding="async" width="272" height="180" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/97/Docking_representation_2.png/408px-Docking_representation_2.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/97/Docking_representation_2.png/544px-Docking_representation_2.png 2x" data-file-width="1385" data-file-height="919" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Docking_representation_2.png" class="internal" title="Enlarge"></a></div>Molecular Docking</div></div></div>
<h3><span class="mw-headline" id="Molecular_docking">Molecular docking</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=21" title="Edit section: Molecular docking">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Docking_(molecular)" title="Docking (molecular)">Molecular docking</a> is an <a href="/wiki/In_silico" title="In silico"><i>in silico</i></a> method used in drug discovery to identify novel compounds of interest. It has the ability to predict the binding conformation of small molecule ligands to their binding site. Docking was first introduced in the 1970s, and allows researchers the ability to predict interactions between the target and potential ligands.<sup id="cite_ref-:2_23-0" class="reference"><a href="#cite_note-:2-23">&#91;23&#93;</a></sup>
</p><p>Molecular docking is currently used for the prediction of targets for compounds, prediction of adverse drug reactions, <a href="/wiki/Polypharmacology" title="Polypharmacology">polypharmaoclogy</a>, virtual screenings, and drug repositioning. Virtual screening using molecular docking utilizes large collections of synthesized and designed molecules to find macromolecule binding sites. Curated molecules are scored based on their binding energies and other parameters.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">&#91;24&#93;</a></sup>
</p><p>Ligand-Based approaches are used to identify suitable protein conformations for the docking screenings. This approach can also be used to confirm the prediction from the docking screenings. Researchers can use the similarity between the predicted binding confirmation and the experimental conformation when the ligand is crystalized with the protein.  <a href="/wiki/Molecular_dynamics" title="Molecular dynamics">Molecular dynamics</a> (MD) and binding free energy estimations are both structure based approaches, often used in combination. Residue flexibility and conformational changes can be evaluated through molecular dynamics. It can be used to determine the stability of different protein conformations. The use of artificial intelligence and statistical methods are new in the molecular docking pipeline.<sup id="cite_ref-:2_23-1" class="reference"><a href="#cite_note-:2-23">&#91;23&#93;</a></sup> These methods can utilize publicly available information on the structural, chemical and activity of compounds for better predictions.
</p>
<h3><span class="mw-headline" id="Molecular_Docking_Programs">Molecular Docking Programs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=22" title="Edit section: Molecular Docking Programs">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<h4><span class="mw-headline" id="DOCK">DOCK</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=23" title="Edit section: DOCK">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><div id="mwe_player_0" class="PopUpMediaTransform" style="width:220px;" videopayload="&lt;div class=&quot;mediaContainer&quot; style=&quot;width:800px&quot;&gt;&lt;video id=&quot;mwe_player_1&quot; poster=&quot;//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv/800px--Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv.jpg&quot; controls=&quot;&quot; preload=&quot;none&quot; autoplay=&quot;&quot; style=&quot;width:800px;height:460px&quot; class=&quot;kskin&quot; data-durationhint=&quot;0.15&quot; data-startoffset=&quot;0&quot; data-mwtitle=&quot;Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv&quot; data-mwprovider=&quot;wikimediacommons&quot;&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/0/0f/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv&quot; type=&quot;video/ogg; codecs=&amp;quot;theora&amp;quot;&quot; data-title=&quot;Original Ogg file, 800 × 460 (120.72 Mbps)&quot; data-shorttitle=&quot;Ogg source&quot; data-width=&quot;800&quot; data-height=&quot;460&quot; data-bandwidth=&quot;120717760&quot; data-framerate=&quot;100&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/0/0f/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv.120p.vp9.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp9, opus&amp;quot;&quot; data-title=&quot;Lowest bandwidth VP9 (120P)&quot; data-shorttitle=&quot;VP9 120P&quot; data-transcodekey=&quot;120p.vp9.webm&quot; data-width=&quot;208&quot; data-height=&quot;120&quot; data-bandwidth=&quot;3610448&quot; data-framerate=&quot;100&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/0/0f/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv.160p.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp8, vorbis&amp;quot;&quot; data-title=&quot;Low bandwidth WebM (160P)&quot; data-shorttitle=&quot;WebM 160P&quot; data-transcodekey=&quot;160p.webm&quot; data-width=&quot;278&quot; data-height=&quot;160&quot; data-bandwidth=&quot;6729864&quot; data-framerate=&quot;100&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/0/0f/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv.180p.vp9.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp9, opus&amp;quot;&quot; data-title=&quot;Low bandwidth VP9 (180P)&quot; data-shorttitle=&quot;VP9 180P&quot; data-transcodekey=&quot;180p.vp9.webm&quot; data-width=&quot;314&quot; data-height=&quot;180&quot; data-bandwidth=&quot;6104688&quot; data-framerate=&quot;100&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/0/0f/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv.240p.vp9.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp9, opus&amp;quot;&quot; data-title=&quot;Small VP9 (240P)&quot; data-shorttitle=&quot;VP9 240P&quot; data-transcodekey=&quot;240p.vp9.webm&quot; data-width=&quot;418&quot; data-height=&quot;240&quot; data-bandwidth=&quot;8359624&quot; data-framerate=&quot;100&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/0/0f/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv.240p.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp8, vorbis&amp;quot;&quot; data-title=&quot;Small WebM (240P)&quot; data-shorttitle=&quot;WebM 240P&quot; data-transcodekey=&quot;240p.webm&quot; data-width=&quot;418&quot; data-height=&quot;240&quot; data-bandwidth=&quot;10770768&quot; data-framerate=&quot;100&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/0/0f/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv.360p.vp9.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp9, opus&amp;quot;&quot; data-title=&quot;VP9 (360P)&quot; data-shorttitle=&quot;VP9 360P&quot; data-transcodekey=&quot;360p.vp9.webm&quot; data-width=&quot;626&quot; data-height=&quot;360&quot; data-bandwidth=&quot;12916640&quot; data-framerate=&quot;100&quot;/&gt;&lt;source src=&quot;//upload.wikimedia.org/wikipedia/commons/transcoded/0/0f/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv.360p.webm&quot; type=&quot;video/webm; codecs=&amp;quot;vp8, vorbis&amp;quot;&quot; data-title=&quot;WebM (360P)&quot; data-shorttitle=&quot;WebM 360P&quot; data-transcodekey=&quot;360p.webm&quot; data-width=&quot;626&quot; data-height=&quot;360&quot; data-bandwidth=&quot;17307304&quot; data-framerate=&quot;100&quot;/&gt;&lt;/video&gt;&lt;/div&gt;"><img alt="File:Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv" style="width:220px;height:127px" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0f/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv/220px--Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv.jpg" /><a href="//upload.wikimedia.org/wikipedia/commons/0/0f/Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv" title="Play media" target="new"><span class="play-btn-large"><span class="mw-tmh-playtext">Play media</span></span></a></div>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Drug-screening-on-Hutchinson-Gilford-progeria-pluripotent-stem-cells-reveals-aminopyrimidines-as-cddis2015374x10.ogv" class="internal" title="Enlarge"></a></div>Molecular Docking</div></div></div>
<p>DOCK was the first docking software, created in the 1980's. DOCK uses an algorithm that searches potential binding modes. DOCK can superimpose the ligand onto the binding pocket and finds the lowest energy binding conformation. In the newer versions, the algorithm can perform both rigid and flexible docking.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="MORDOR">MORDOR</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=24" title="Edit section: MORDOR">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>MOlecular Recognition with a Driven dynamics OptimizeR (MORDOR) is a docking software designed for accurate docking predictions. In experimental observations, a ligand can affect the conformation of a receptor. MORDOR takes this into consideration and allows for induced fit; the simulation moves with the ligand. The ligand is also able to explore the different possible binding pockets. The software uses DOCK to perform rigid docking to reduce the size of the library. After curating a smaller library, MODOR is used. MORDOR uses a "dummy sphere" to move along the receptor to identify different binding pockets. The result is an energy map with all known binding pockets.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26">&#91;26&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="AMBER">AMBER</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=25" title="Edit section: AMBER">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Amber21_cover.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Amber21_cover.png/220px-Amber21_cover.png" decoding="async" width="220" height="267" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Amber21_cover.png/330px-Amber21_cover.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Amber21_cover.png/440px-Amber21_cover.png 2x" data-file-width="1054" data-file-height="1280" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Amber21_cover.png" class="internal" title="Enlarge"></a></div>AMBER 2021 Reference Manual</div></div></div>
<p><a href="/wiki/AMBER" title="AMBER">Assisted Model Building with Energy Refinement (AMBER)</a> was created in 2002 by developers at the University of California, San Francisco. AMBER refers to a set of "force fields" that simulate biomolecules and refers to the software package that simulated a family of force fields for molecular dynamics. "Force fields" are the parameters of the bonds, angles, dihedrals, and atom types within the system.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">&#91;27&#93;</a></sup> The suite allows users to complete full molecular dynamics simulations with water or Born solvent models. &#160;
</p>
<table class="wikitable">
<caption>Databases Used in Inverse Docking Target Identification
</caption>
<tbody><tr>
<th>Database Name
</th>
<th>Information
</th></tr>
<tr>
<td><a rel="nofollow" class="external text" href="https://www.rcsb.org/">Protein Data Bank</a>
</td>
<td>Structure of proteins
</td></tr>
<tr>
<td><a rel="nofollow" class="external text" href="https://www.uniprot.org/">Uniprot</a>
</td>
<td>Protein sequence and functional information
</td></tr>
<tr>
<td><a href="/wiki/Therapeutic_Targets_Database" title="Therapeutic Targets Database">Therapeutic Target Database</a>
</td>
<td>Therapeutic protein and nucleic acid targets, disease, disease pathway information, drugs
</td></tr>
<tr>
<td><a rel="nofollow" class="external text" href="http://bioinfo-pharma.u-strasbg.fr/scPDB/">sc-PDB</a>
</td>
<td>Proteins, ligands, binding sites
</td></tr>
<tr>
<td>Potential Drug Target Database
</td>
<td>Binding structures, disease, biological activity
</td></tr>
<tr>
<td><a rel="nofollow" class="external text" href="https://go.drugbank.com/">Drug Bank</a>
</td>
<td>Drug and drug targets
</td></tr>
<tr>
<td><a rel="nofollow" class="external text" href="https://pubchem.ncbi.nlm.nih.gov/">PubChem</a>
</td>
<td>Structure and activity of chemicals
</td></tr>
<tr>
<td><a rel="nofollow" class="external text" href="https://www.ebi.ac.uk/chembl/">ChEMBL</a>
</td>
<td>Drug-like compounds
</td></tr>
<tr>
<td>Drug Adverse Reaction Target Database (DART)
</td>
<td>Targets associated with ADR
</td></tr>
<tr>
<td>Drug Induced Toxicity Related Protein Database (DITROP)
</td>
<td>Targets associated with toxicity
</td></tr></tbody></table>
<h3><span class="mw-headline" id="Reverse_docking">Reverse docking</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=26" title="Edit section: Reverse docking">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:420px;"><a href="/wiki/File:Docking-reverse_and_classical.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Docking-reverse_and_classical.png/418px-Docking-reverse_and_classical.png" decoding="async" width="418" height="232" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Docking-reverse_and_classical.png/627px-Docking-reverse_and_classical.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Docking-reverse_and_classical.png/836px-Docking-reverse_and_classical.png 2x" data-file-width="2268" data-file-height="1260" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Docking-reverse_and_classical.png" class="internal" title="Enlarge"></a></div>Classical and reverse docking</div></div></div>
<p>Reverse docking, or inverse docking, is an <i>in silico</i> method to find proteins targets to a specific ligand.<sup id="cite_ref-:2_23-2" class="reference"><a href="#cite_note-:2-23">&#91;23&#93;</a></sup> Much like regular docking methods, ligand-target conformations are scored and ranked based on preset parameters.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup>  Large and properly constructed databases need to be created with target structures. These databases also need to define the binding sites for each proteins. There are multiple reverse docking tools that use a variety of databases and can be used in identifying targets and potential off-target interactions. The problem with efficacy of reverse docking comes from high computational time and lack of databases for target structures.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Reverse_docking_programs">Reverse docking programs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=27" title="Edit section: Reverse docking programs">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<h4><span class="mw-headline" id="INVDOCK">INVDOCK</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=28" title="Edit section: INVDOCK">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>INVDOCK was the first reverse docking tool, created in 2001. This software aligns ligands to the binding site and binding conformations are analyzed using energy minimization. INVDOCK can be used to identify unknown and secondary targets of drugs, leads, etc. It can also predict the <a href="/wiki/ADME" title="ADME">ADME</a> of targets.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">&#91;30&#93;</a></sup> One of the limitations of INVDOCK is the lack of optimization; users input a threshold binding energy and once the ligand is positioned successfully, within the binding energy threshold, the program moves on. There is no optimization for multiple low energy conformations.
</p>
<h4><span class="mw-headline" id="TarFisDock">TarFisDock</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=29" title="Edit section: TarFisDock">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>TarFisDock was first developed in 2006 and is a tool that ranks targets using an in-house database, Potential Drug Target Database (PDTD).<sup id="cite_ref-:3_31-0" class="reference"><a href="#cite_note-:3-31">&#91;31&#93;</a></sup> This tool calculates the binding energy of targets and their ligands. Users input their small molecule to be tested and TarFisDock searches for proteins using docking techniques. Viable targets are usually contained in the top 2,5, or 10% of its rankings.
</p>
<h4><span class="mw-headline" id="idTarget">idTarget</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=30" title="Edit section: idTarget">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>idTarget is a web based docking tool that allows for multiple binding sites of a protein to be identified.<sup id="cite_ref-:3_31-1" class="reference"><a href="#cite_note-:3-31">&#91;31&#93;</a></sup> This tool uses all the protein structures within the Protein Data Bank (PDB). This tool is also able to determine off targets of compounds.
</p>
<h3><span class="mw-headline" id="Challenges_with_molecular_docking">Challenges with molecular docking</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=31" title="Edit section: Challenges with molecular docking">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Molecular is a powerful took for visualization of ligand-target interactions. Molecular docking does not always correctly predict the binding modes due to the algorithms being estimations. Flexibility of binding sites and molecules can cause false binding sites that do not exist in experimental observation. Accurate prediction of binding is limited by size of both the ligand and receptor and knowledge surrounding the receptor. There are also problems with the scoring functions of virtual docking platforms. Commonly these scoring functions are based on binding affinity estimations. Entropy, atom randomization, binding flexibility are the most challenging issues related to predicting the binding affinity.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32">&#91;32&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Orphan_receptors">Orphan receptors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=32" title="Edit section: Orphan receptors">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p><a href="/wiki/Orphan_receptor" title="Orphan receptor">Orphan receptors</a> are protein receptors that are activated by unknown ligands. Though the ligands for these receptors are unknown, their structures are often similar to already identified receptors. Orphan receptors generally are apart of two distinct receptor families: <a href="/wiki/Nuclear_receptor" title="Nuclear receptor">nuclear receptors</a> and <a href="/wiki/G_protein-coupled_receptor" title="G protein-coupled receptor">G protein coupled receptors (GPCR)</a>. Nuclear receptors are cytosolic proteins that act as t<a href="/wiki/Transcription_factor" title="Transcription factor">ranscription factors</a> once activated. GPCRs are seven transmembrane receptors that activate <a href="/wiki/G_protein" title="G protein">G proteins</a> which signal transduce down stream effector proteins.There are more than 700 genes that code for GPCRs. It is thought that of these 700 genes, around half code for sensory receptors and the remaining may have viability as potential drug targets. Currently, more than 200 ligands for these GPCRs have been identified, leaving around 150 receptors orphaned. It is important to develop a suitable assay to successfully identify ligands.<sup id="cite_ref-:5_33-0" class="reference"><a href="#cite_note-:5-33">&#91;33&#93;</a></sup>
</p><p>Currently, receptor sequences can be cloned and their structural information determined. These structures can be compared to GPCRs with known ligands; receptor activity can be predicted if an orphan receptor has significant homology to a receptor with known ligands. Further functional identification is done using functional assays.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34">&#91;34&#93;</a></sup> Commonly, the cDNA of the GPCR of interest is expressed in relevant cell lines and used as bait to determine endogenous ligands.
</p><p>The first GPCRs to be deorphanized were the <a href="/wiki/5-HT1A_receptor" title="5-HT1A receptor">serotonin 1A receptor (5-HT1A)</a> and the D2 dopamine receptors. It is thought that there are more GPCRs than known potential ligands; these receptors bind to characterized ligands.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35">&#91;35&#93;</a></sup>
</p><p>Orphan GPCRs are categorized into three classes: <a rel="nofollow" class="external text" href="https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=16">Class A</a>, <a rel="nofollow" class="external text" href="https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=17">Class B (adhesion GPCRs)</a> , and <a rel="nofollow" class="external text" href="https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=18">Class C</a>. Class A orphans have preliminary evidence for an endogenous ligand that has been published and linked to a disease. Class G, or adhesion, GPCRs are identified based on their extracellular region. The N terminal shares similar homology with adhesive domains. Class C orphans  do not have a known endogenous ligand.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">&#91;36&#93;</a></sup>
</p>
<table class="wikitable">
<caption>Class A Orphans: GPCRs with putative endogenous ligands<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">&#91;37&#93;</a></sup>
</caption>
<tbody><tr>
<td>GPR3
</td>
<td>GPR4
</td>
<td>GPR6
</td>
<td>GPR15
</td>
<td>GPR17
</td>
<td>GPR17
</td>
<td>GPR20
</td></tr>
<tr>
<td>GPR22
</td>
<td>GPR26
</td>
<td>GPR31
</td>
<td>GPR35
</td>
<td>GPR37
</td>
<td>GPR37
</td>
<td>GPR39
</td></tr>
<tr>
<td>GPR50
</td>
<td>GPR63
</td>
<td>GPR68
</td>
<td>GPR75
</td>
<td>GPR84
</td>
<td>GPR84
</td>
<td>GPR87
</td></tr>
<tr>
<td>GPR88
</td>
<td>GPR132
</td>
<td>GPR161
</td>
<td>GPR183
</td>
<td>LGR4
</td>
<td>LGR4
</td>
<td>LGR5
</td></tr>
<tr>
<td>LGR6
</td>
<td>MAS1
</td>
<td>MRGPRX1
</td>
<td>MRGPRX2
</td>
<td>P2RY10
</td>
<td>P2RY10
</td>
<td>TAAR2
</td></tr></tbody></table>
<table class="wikitable">
<caption>Class B (Adhesion) Orphans<sup id="cite_ref-38" class="reference"><a href="#cite_note-38">&#91;38&#93;</a></sup>
</caption>
<tbody><tr>
<td>ADGRA1
</td>
<td>ADGRB3
</td>
<td>ADGRD2
</td>
<td>ADGRE5
</td>
<td>ADGRF5
</td>
<td>ADGRG5
</td>
<td>ADGRL3
</td></tr>
<tr>
<td>ADGRA2
</td>
<td>CELSR1/ADGRC1
</td>
<td>ADGRE1
</td>
<td>ADGRF1
</td>
<td>ADGRG1
</td>
<td>ADGRG6
</td>
<td>ADGRL4
</td></tr>
<tr>
<td>ADGRA3
</td>
<td>CELSR2/ADGRC2
</td>
<td>ADGRE2
</td>
<td>ADGRF2
</td>
<td>ADGRG2
</td>
<td>ADGRG7
</td>
<td>ADGRV1
</td></tr>
<tr>
<td>ADGRB1
</td>
<td>CELSR3/ADGRC3
</td>
<td>ADGRE3
</td>
<td>ADGRF3
</td>
<td>ADGRG3
</td>
<td>ADGRL1
</td>
<td>
</td></tr>
<tr>
<td>ADGRB2
</td>
<td>ADGRD1
</td>
<td>ADGRE4P
</td>
<td>ADGRF4
</td>
<td>ADGRG4
</td>
<td>ADGRL2
</td>
<td>
</td></tr></tbody></table>
<table class="wikitable">
<caption>Class C Orphans: GPCRs no known endogenous ligands<sup id="cite_ref-39" class="reference"><a href="#cite_note-39">&#91;39&#93;</a></sup>
</caption>
<tbody><tr>
<td>GRP156
</td>
<td>GPRC5B
</td></tr>
<tr>
<td>GPR158
</td>
<td>GPRC5C
</td></tr>
<tr>
<td>GPR179
</td>
<td>GPRC5D
</td></tr>
<tr>
<td>GPRC5A
</td>
<td>GPRC6 receptor
</td></tr></tbody></table>
<h3><span class="mw-headline" id="Functional_assays_for_identifying_orphaned_GPCRs">Functional assays for identifying orphaned GPCRs</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=33" title="Edit section: Functional assays for identifying orphaned GPCRs">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<h4><span id="Bioluminescent_energy_transfer_.28BRET.29"></span><span class="mw-headline" id="Bioluminescent_energy_transfer_(BRET)">Bioluminescent energy transfer (BRET)</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=34" title="Edit section: Bioluminescent energy transfer (BRET)">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>Generation of assays are important for "deorphanizing" these receptors. <a href="/wiki/Arrestin" title="Arrestin">β-arrestin</a> has been used to deorphanize GPCRs. Measuring the recruitment of β-arrestin can provide insight into the internalization of GPCRs. Once the GPCR becomes activated and <a href="/wiki/Phosphorylation" title="Phosphorylation">phosphorylated</a>,  β-arrestin is recruited to the cell surface. Researchers have created a chimeric β-arrestin attached to green fluorescent protein (GFP) so that it can be tracked throughout the cell. Activation of a GPCR is indicated by the chimeric β-arrestin being compartmentalized. This technique has been utilized for the deorphanization of Drosophila neuropeptide receptors.<sup id="cite_ref-:5_33-1" class="reference"><a href="#cite_note-:5-33">&#91;33&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Adaption_of_pheromone_receptor_pathway">Adaption of pheromone receptor pathway</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=35" title="Edit section: Adaption of pheromone receptor pathway">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>This assays is useful in identifying the specificity of G protein coupling to the orphan receptor. Chimeric G protein are used to enable to <i><a href="/wiki/Saccharomyces_cerevisiae" title="Saccharomyces cerevisiae">Saccharomyces cerevisiae</a></i> G-Protein, Gpa1, linked signaling through the MAPKinase cascade. This assay give low background due lack of endogenous GPCR background.<sup id="cite_ref-:5_33-2" class="reference"><a href="#cite_note-:5-33">&#91;33&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Bead-based_screening_with_Xenopus_melanophores">Bead-based screening with <i>Xenopus melanophores</i></span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=36" title="Edit section: Bead-based screening with Xenopus melanophores">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><a href="/wiki/Signaling_peptide_receptor" title="Signaling peptide receptor">Peptide receptors</a> are receptors that binds to multiple peptides or signaling proteins. Many of these receptors have been implicated in diseases. Using combinatorial chemistry, GPCRs that respond to peptide ligands may be able to be identified. Beads of potential ligand peptides are first pooled so that each pool would have the same first amino acid. "Lawns" containing melanophores are transfected with peptide multiple receptor sets. These were groups of both receptors with known ligands and receptors that were orphaned. The beads are spread on the "lawn" and GPCR activation is determined through pigment translocation, which is dependent on G protein signaling. The peptides on these beads can then be sequenced for further assays.<sup id="cite_ref-:5_33-3" class="reference"><a href="#cite_note-:5-33">&#91;33&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Pharmacochaperone_screening_assay">Pharmacochaperone screening assay</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=37" title="Edit section: Pharmacochaperone screening assay">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>A <a href="/wiki/Pharmacological_chaperone" title="Pharmacological chaperone">pharmacochaperone</a> is a drug that acts as a chaperone for a protein. These <a href="/wiki/Chaperone_(protein)" title="Chaperone (protein)">chaperones</a> assist with the folding/ unfolding and assembly/disassembly of macromolecule structures. Pharmacochaperones correct  the folding of misfolded and unfolded proteins, allowing them to be correctly routed in the cel's system. The pharmacochaperone screening assay exploits pharmacochaperones, small molecules that allow for the trafficking of receptors to the plasma membrane, to identify ligands. A point mutation is introduced which causes the receptor to be retained in the endoplasmic reticulum. As a result, molecules that act as chaperones will bring the receptor to the surface. These molecules are coupled with a beta-galactosidase reporter system for identification.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">&#91;40&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Identification_of_orexin">Identification of orexin</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=38" title="Edit section: Identification of orexin">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:MMDB_ID_29295_PDB_ID_1R02_Structure_Of_Human_Orexin-A.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/6e/MMDB_ID_29295_PDB_ID_1R02_Structure_Of_Human_Orexin-A.png/220px-MMDB_ID_29295_PDB_ID_1R02_Structure_Of_Human_Orexin-A.png" decoding="async" width="220" height="124" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/6e/MMDB_ID_29295_PDB_ID_1R02_Structure_Of_Human_Orexin-A.png/330px-MMDB_ID_29295_PDB_ID_1R02_Structure_Of_Human_Orexin-A.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/6e/MMDB_ID_29295_PDB_ID_1R02_Structure_Of_Human_Orexin-A.png/440px-MMDB_ID_29295_PDB_ID_1R02_Structure_Of_Human_Orexin-A.png 2x" data-file-width="4096" data-file-height="2311" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:MMDB_ID_29295_PDB_ID_1R02_Structure_Of_Human_Orexin-A.png" class="internal" title="Enlarge"></a></div>Structure of Human Orexin-A</div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:MMDB_ID_12437_PDB_ID_1CQ0_Structure_Of_A_Human_Hypocretin-2_OREXIN-_B.png" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9a/MMDB_ID_12437_PDB_ID_1CQ0_Structure_Of_A_Human_Hypocretin-2_OREXIN-_B.png/220px-MMDB_ID_12437_PDB_ID_1CQ0_Structure_Of_A_Human_Hypocretin-2_OREXIN-_B.png" decoding="async" width="220" height="124" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9a/MMDB_ID_12437_PDB_ID_1CQ0_Structure_Of_A_Human_Hypocretin-2_OREXIN-_B.png/330px-MMDB_ID_12437_PDB_ID_1CQ0_Structure_Of_A_Human_Hypocretin-2_OREXIN-_B.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9a/MMDB_ID_12437_PDB_ID_1CQ0_Structure_Of_A_Human_Hypocretin-2_OREXIN-_B.png/440px-MMDB_ID_12437_PDB_ID_1CQ0_Structure_Of_A_Human_Hypocretin-2_OREXIN-_B.png 2x" data-file-width="4096" data-file-height="2311" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:MMDB_ID_12437_PDB_ID_1CQ0_Structure_Of_A_Human_Hypocretin-2_OREXIN-_B.png" class="internal" title="Enlarge"></a></div>Structure of Orexin-B</div></div></div>
<p><a href="/wiki/Orexin" title="Orexin">Orexins</a> are <a href="/wiki/Neuropeptide" title="Neuropeptide">neuropeptides</a>, important for their role in energy homeostasis and regulate sleep/wakefulness. Takeshi Sakurai and their lab were able to identify orexin-A and orexin-B, two endogenous ligands for two orphan GPCRs. Their lab identified orexin peptides that were able to express orexin-1 receptor (OX<sub>1</sub>R). This receptor has high affinity for orexin-A. the second receptor, orexin-2 (OX<sub>2</sub>R) binds both orexin-A and B at the same affinity. They used 50 transfectant cell lines, expressing multiple orphan GPCR cDNA. Cells were challenged with <a href="/wiki/High-performance_liquid_chromatography" title="High-performance liquid chromatography">high performance liquid chromatography (HPLC</a>) fractions and monitored for signal transduction.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41">&#91;41&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=39" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><a href="/wiki/Classical_pharmacology" title="Classical pharmacology">Classical pharmacology</a></li></ul>
<div style="clear:both;"></div>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit&amp;section=40" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1011085734">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist reflist-columns references-column-width" style="column-width: 32em;">
<ol class="references">
<li id="cite_note-pmid11589663-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid11589663_1-0">^</a></b></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1067248974">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite id="CITEREFTakenaka2001" class="citation journal cs1 cs1-prop-long-vol">Takenaka T (Sep 2001). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1464-410X.2001.00112.x">"Classical vs reverse pharmacology in drug discovery"</a>. <i>BJU International</i>. 88 Suppl 2: 7–10, discussion 49–50. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1464-410X.2001.00112.x">10.1111/j.1464-410X.2001.00112.x</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11589663">11589663</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BJU+International&amp;rft.atitle=Classical+vs+reverse+pharmacology+in+drug+discovery&amp;rft.volume=88+Suppl+2&amp;rft.pages=7-10%2C+discussion+49-50&amp;rft.date=2001-09&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1464-410X.2001.00112.x&amp;rft_id=info%3Apmid%2F11589663&amp;rft.aulast=Takenaka&amp;rft.aufirst=T&amp;rft_id=%2F%2Fdoi.org%2F10.1111%252Fj.1464-410X.2001.00112.x&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid18403648-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid18403648_2-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLazo2008" class="citation journal cs1">Lazo JS (Apr 2008). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pubmed?term=Rear-view%20mirrors%20and%20crystal%20balls">"Rear-view mirrors and crystal balls: a brief reflection on drug discovery"</a>. <i>Molecular Interventions</i>. <b>8</b> (2): 60–3. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1124%2Fmi.8.2.1">10.1124/mi.8.2.1</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/18403648">18403648</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+Interventions&amp;rft.atitle=Rear-view+mirrors+and+crystal+balls%3A+a+brief+reflection+on+drug+discovery&amp;rft.volume=8&amp;rft.issue=2&amp;rft.pages=60-3&amp;rft.date=2008-04&amp;rft_id=info%3Adoi%2F10.1124%2Fmi.8.2.1&amp;rft_id=info%3Apmid%2F18403648&amp;rft.aulast=Lazo&amp;rft.aufirst=JS&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%3Fterm%3DRear-view%2520mirrors%2520and%2520crystal%2520balls&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-isbn0-12-369521-X-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-isbn0-12-369521-X_3-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBachmannHackerMesser2009" class="citation book cs1">Bachmann KA, Hacker MP, Messer W (2009). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=5YDMmjWXe-AC&amp;q=reverse+pharmacology&amp;pg=PA576"><i>Pharmacology Principles and Practice</i></a>. Amsterdam: Elsevier/Academic Press. p.&#160;576. <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-12-369521-5" title="Special:BookSources/978-0-12-369521-5"><bdi>978-0-12-369521-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Pharmacology+Principles+and+Practice&amp;rft.place=Amsterdam&amp;rft.pages=576&amp;rft.pub=Elsevier%2FAcademic+Press&amp;rft.date=2009&amp;rft.isbn=978-0-12-369521-5&amp;rft.aulast=Bachmann&amp;rft.aufirst=KA&amp;rft.au=Hacker%2C+MP&amp;rft.au=Messer%2C+W&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D5YDMmjWXe-AC%26q%3Dreverse%2Bpharmacology%26pg%3DPA576&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid22409666-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid22409666_4-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLeeUhlikMoxhamTomandl2012" class="citation journal cs1">Lee JA, Uhlik MT, Moxham CM, Tomandl D, Sall DJ (May 2012). "Modern phenotypic drug discovery is a viable, neoclassic pharma strategy". <i>Journal of Medicinal Chemistry</i>. <b>55</b> (10): 4527–38. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1021%2Fjm201649s">10.1021/jm201649s</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/22409666">22409666</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Medicinal+Chemistry&amp;rft.atitle=Modern+phenotypic+drug+discovery+is+a+viable%2C+neoclassic+pharma+strategy&amp;rft.volume=55&amp;rft.issue=10&amp;rft.pages=4527-38&amp;rft.date=2012-05&amp;rft_id=info%3Adoi%2F10.1021%2Fjm201649s&amp;rft_id=info%3Apmid%2F22409666&amp;rft.aulast=Lee&amp;rft.aufirst=JA&amp;rft.au=Uhlik%2C+MT&amp;rft.au=Moxham%2C+CM&amp;rft.au=Tomandl%2C+D&amp;rft.au=Sall%2C+DJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-Swinney_2011-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-Swinney_2011_5-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSwinneyAnthony2011" class="citation journal cs1">Swinney DC, Anthony J (Jul 2011). "How were new medicines discovered?". <i>Nature Reviews. Drug Discovery</i>. <b>10</b> (7): 507–19. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrd3480">10.1038/nrd3480</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21701501">21701501</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:19171881">19171881</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Drug+Discovery&amp;rft.atitle=How+were+new+medicines+discovered%3F&amp;rft.volume=10&amp;rft.issue=7&amp;rft.pages=507-19&amp;rft.date=2011-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19171881%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21701501&amp;rft_id=info%3Adoi%2F10.1038%2Fnrd3480&amp;rft.aulast=Swinney&amp;rft.aufirst=DC&amp;rft.au=Anthony%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-Blondeau_1682–1696-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-Blondeau_1682–1696_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Blondeau_1682–1696_6-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBlondeauDoSciorBernard2010" class="citation journal cs1">Blondeau, S.; Do, Q.T.; Scior, T.; Bernard, P.; Morin-Allory, L. (2010-05-01). <a rel="nofollow" class="external text" href="https://dx.doi.org/10.2174/138161210791164036">"Reverse Pharmacognosy: Another Way to Harness the Generosity of Nature"</a>. <i>Current Pharmaceutical Design</i>. <b>16</b> (15): 1682–1696. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F138161210791164036">10.2174/138161210791164036</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1381-6128">1381-6128</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20222859">20222859</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Pharmaceutical+Design&amp;rft.atitle=Reverse+Pharmacognosy%3A+Another+Way+to+Harness+the+Generosity+of+Nature&amp;rft.volume=16&amp;rft.issue=15&amp;rft.pages=1682-1696&amp;rft.date=2010-05-01&amp;rft.issn=1381-6128&amp;rft_id=info%3Apmid%2F20222859&amp;rft_id=info%3Adoi%2F10.2174%2F138161210791164036&amp;rft.aulast=Blondeau&amp;rft.aufirst=S.&amp;rft.au=Do%2C+Q.T.&amp;rft.au=Scior%2C+T.&amp;rft.au=Bernard%2C+P.&amp;rft.au=Morin-Allory%2C+L.&amp;rft_id=http%3A%2F%2Fdx.doi.org%2F10.2174%2F138161210791164036&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-:4-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-:4_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:4_7-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFRappuoli2000" class="citation journal cs1">Rappuoli, Rino (2000). "Reverse vaccinology". <i>Current Opinion in Microbiology</i>. <b>3</b> (5): 445–450. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS1369-5274%2800%2900119-3">10.1016/S1369-5274(00)00119-3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11050440">11050440</a> &#8211; via Elseiver Science Ltd.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Microbiology&amp;rft.atitle=Reverse+vaccinology&amp;rft.volume=3&amp;rft.issue=5&amp;rft.pages=445-450&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1016%2FS1369-5274%2800%2900119-3&amp;rft_id=info%3Apmid%2F11050440&amp;rft.aulast=Rappuoli&amp;rft.aufirst=Rino&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSetteRappuoli2010" class="citation journal cs1">Sette, Alessandro; Rappuoli, Rino (October 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3320742">"Reverse Vaccinology: Developing Vaccines in the Era of Genomics"</a>. <i>Immunity</i>. <b>33</b> (4): 530–541. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.immuni.2010.09.017">10.1016/j.immuni.2010.09.017</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3320742">3320742</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/21029963">21029963</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Immunity&amp;rft.atitle=Reverse+Vaccinology%3A+Developing+Vaccines+in+the+Era+of+Genomics&amp;rft.volume=33&amp;rft.issue=4&amp;rft.pages=530-541&amp;rft.date=2010-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3320742%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F21029963&amp;rft_id=info%3Adoi%2F10.1016%2Fj.immuni.2010.09.017&amp;rft.aulast=Sette&amp;rft.aufirst=Alessandro&amp;rft.au=Rappuoli%2C+Rino&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3320742&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHanssonNygrenStåhl2000" class="citation journal cs1">Hansson, Marianne; Nygren, Per-Åke; Ståhl, Stefan (2000-10-01). <a rel="nofollow" class="external text" href="https://dx.doi.org/10.1042/ba20000034">"Design and production of recombinant subunit vaccines"</a>. <i>Biotechnology and Applied Biochemistry</i>. <b>32</b> (2): 95–107. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1042%2Fba20000034">10.1042/ba20000034</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0885-4513">0885-4513</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11001870">11001870</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:19091795">19091795</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biotechnology+and+Applied+Biochemistry&amp;rft.atitle=Design+and+production+of+recombinant+subunit+vaccines&amp;rft.volume=32&amp;rft.issue=2&amp;rft.pages=95-107&amp;rft.date=2000-10-01&amp;rft.issn=0885-4513&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19091795%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11001870&amp;rft_id=info%3Adoi%2F10.1042%2Fba20000034&amp;rft.aulast=Hansson&amp;rft.aufirst=Marianne&amp;rft.au=Nygren%2C+Per-%C3%85ke&amp;rft.au=St%C3%A5hl%2C+Stefan&amp;rft_id=http%3A%2F%2Fdx.doi.org%2F10.1042%2Fba20000034&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-:0-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-:0_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:0_10-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFBrunoCorteseRappuoliMerola2015" class="citation journal cs1">Bruno, Luca; Cortese, Mirko; Rappuoli, Rino; Merola, Marcello (2015-04-01). <a rel="nofollow" class="external text" href="https://www.sciencedirect.com/science/article/pii/S1879625715000322">"Lessons from Reverse Vaccinology for viral vaccine design"</a>. <i>Current Opinion in Virology</i>. Viral pathogenesis • Preventive and therapeutic vaccines. <b>11</b>: 89–97. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.coviro.2015.03.001">10.1016/j.coviro.2015.03.001</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1879-6257">1879-6257</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25829256">25829256</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Virology&amp;rft.atitle=Lessons+from+Reverse+Vaccinology+for+viral+vaccine+design&amp;rft.volume=11&amp;rft.pages=89-97&amp;rft.date=2015-04-01&amp;rft.issn=1879-6257&amp;rft_id=info%3Apmid%2F25829256&amp;rft_id=info%3Adoi%2F10.1016%2Fj.coviro.2015.03.001&amp;rft.aulast=Bruno&amp;rft.aufirst=Luca&amp;rft.au=Cortese%2C+Mirko&amp;rft.au=Rappuoli%2C+Rino&amp;rft.au=Merola%2C+Marcello&amp;rft_id=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS1879625715000322&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHeinsonWoelkNewell2015" class="citation journal cs1">Heinson, A. I.; Woelk, C. H.; Newell, M.-L. (2015-03-01). <a rel="nofollow" class="external text" href="https://doi.org/10.1093/inthealth/ihv002">"The promise of reverse vaccinology"</a>. <i>International Health</i>. <b>7</b> (2): 85–89. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Finthealth%2Fihv002">10.1093/inthealth/ihv002</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1876-3413">1876-3413</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25733557">25733557</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Health&amp;rft.atitle=The+promise+of+reverse+vaccinology&amp;rft.volume=7&amp;rft.issue=2&amp;rft.pages=85-89&amp;rft.date=2015-03-01&amp;rft.issn=1876-3413&amp;rft_id=info%3Apmid%2F25733557&amp;rft_id=info%3Adoi%2F10.1093%2Finthealth%2Fihv002&amp;rft.aulast=Heinson&amp;rft.aufirst=A.+I.&amp;rft.au=Woelk%2C+C.+H.&amp;rft.au=Newell%2C+M.-L.&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%2Finthealth%2Fihv002&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDalsassBrozziMediniRappuoli2019" class="citation journal cs1">Dalsass, Mattia; Brozzi, Alessandro; Medini, Duccio; Rappuoli, Rino (2019-02-14). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6382693">"Comparison of Open-Source Reverse Vaccinology Programs for Bacterial Vaccine Antigen Discovery"</a>. <i>Frontiers in Immunology</i>. <b>10</b>: 113. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffimmu.2019.00113">10.3389/fimmu.2019.00113</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1664-3224">1664-3224</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6382693">6382693</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30837982">30837982</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Immunology&amp;rft.atitle=Comparison+of+Open-Source+Reverse+Vaccinology+Programs+for+Bacterial+Vaccine+Antigen+Discovery&amp;rft.volume=10&amp;rft.pages=113&amp;rft.date=2019-02-14&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6382693%23id-name%3DPMC&amp;rft.issn=1664-3224&amp;rft_id=info%3Apmid%2F30837982&amp;rft_id=info%3Adoi%2F10.3389%2Ffimmu.2019.00113&amp;rft.aulast=Dalsass&amp;rft.aufirst=Mattia&amp;rft.au=Brozzi%2C+Alessandro&amp;rft.au=Medini%2C+Duccio&amp;rft.au=Rappuoli%2C+Rino&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6382693&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHeXiangMobley2010" class="citation journal cs1">He, Yongqun; Xiang, Zuoshuang; Mobley, Harry L. T. (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2910479">"Vaxign: The First Web-Based Vaccine Design Program for Reverse Vaccinology and Applications for Vaccine Development"</a>. <i>Journal of Biomedicine and Biotechnology</i>. <b>2010</b>: 297505. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1155%2F2010%2F297505">10.1155/2010/297505</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1110-7243">1110-7243</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2910479">2910479</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20671958">20671958</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Biomedicine+and+Biotechnology&amp;rft.atitle=Vaxign%3A+The+First+Web-Based+Vaccine+Design+Program+for+Reverse+Vaccinology+and+Applications+for+Vaccine+Development&amp;rft.volume=2010&amp;rft.pages=297505&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2910479%23id-name%3DPMC&amp;rft.issn=1110-7243&amp;rft_id=info%3Apmid%2F20671958&amp;rft_id=info%3Adoi%2F10.1155%2F2010%2F297505&amp;rft.aulast=He&amp;rft.aufirst=Yongqun&amp;rft.au=Xiang%2C+Zuoshuang&amp;rft.au=Mobley%2C+Harry+L.+T.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2910479&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFXiangHe2009" class="citation journal cs1">Xiang, Z; He, Y (2009). "Vaxign: a web-based vaccine target design program for reverse vaccinology". <i>Procedia in Vaccinology</i>. <b>1</b>: 23–29. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.provac.2009.07.005">10.1016/j.provac.2009.07.005</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Procedia+in+Vaccinology&amp;rft.atitle=Vaxign%3A+a+web-based+vaccine+target+design+program+for+reverse+vaccinology&amp;rft.volume=1&amp;rft.pages=23-29&amp;rft.date=2009&amp;rft_id=info%3Adoi%2F10.1016%2Fj.provac.2009.07.005&amp;rft.aulast=Xiang&amp;rft.aufirst=Z&amp;rft.au=He%2C+Y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFHeXiangMobley2010" class="citation journal cs1">He, Yongqun; Xiang, Zuoshuang; Mobley, Harry L. T. (2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2910479">"Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development"</a>. <i>Journal of Biomedicine &amp; Biotechnology</i>. <b>2010</b>: 297505. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1155%2F2010%2F297505">10.1155/2010/297505</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1110-7251">1110-7251</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2910479">2910479</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/20671958">20671958</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Biomedicine+%26+Biotechnology&amp;rft.atitle=Vaxign%3A+the+first+web-based+vaccine+design+program+for+reverse+vaccinology+and+applications+for+vaccine+development&amp;rft.volume=2010&amp;rft.pages=297505&amp;rft.date=2010&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2910479%23id-name%3DPMC&amp;rft.issn=1110-7251&amp;rft_id=info%3Apmid%2F20671958&amp;rft_id=info%3Adoi%2F10.1155%2F2010%2F297505&amp;rft.aulast=He&amp;rft.aufirst=Yongqun&amp;rft.au=Xiang%2C+Zuoshuang&amp;rft.au=Mobley%2C+Harry+L.+T.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2910479&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFOngWangWongSeetharaman2020" class="citation journal cs1">Ong, Edison; Wang, Haihe; Wong, Mei U.; Seetharaman, Meenakshi; Valdez, Ninotchka; He, Yongqun (2020-05-01). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7214037">"Vaxign-ML: supervised machine learning reverse vaccinology model for improved prediction of bacterial protective antigens"</a>. <i>Bioinformatics (Oxford, England)</i>. <b>36</b> (10): 3185–3191. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fbioinformatics%2Fbtaa119">10.1093/bioinformatics/btaa119</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1367-4811">1367-4811</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7214037">7214037</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/32096826">32096826</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bioinformatics+%28Oxford%2C+England%29&amp;rft.atitle=Vaxign-ML%3A+supervised+machine+learning+reverse+vaccinology+model+for+improved+prediction+of+bacterial+protective+antigens&amp;rft.volume=36&amp;rft.issue=10&amp;rft.pages=3185-3191&amp;rft.date=2020-05-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7214037%23id-name%3DPMC&amp;rft.issn=1367-4811&amp;rft_id=info%3Apmid%2F32096826&amp;rft_id=info%3Adoi%2F10.1093%2Fbioinformatics%2Fbtaa119&amp;rft.aulast=Ong&amp;rft.aufirst=Edison&amp;rft.au=Wang%2C+Haihe&amp;rft.au=Wong%2C+Mei+U.&amp;rft.au=Seetharaman%2C+Meenakshi&amp;rft.au=Valdez%2C+Ninotchka&amp;rft.au=He%2C+Yongqun&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7214037&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDe_GrootJesdaleSzuSchafer1997" class="citation journal cs1">De Groot, Anne S.; Jesdale, Bill M.; Szu, Evan; Schafer, James R.; Chicz, Roman M.; Deocampo, Greg (May 1997). <a rel="nofollow" class="external text" href="http://www.liebertpub.com/doi/10.1089/aid.1997.13.529">"An Interactive Web Site Providing Major Histocompatibility Ligand Predictions: Application to HIV Research"</a>. <i>AIDS Research and Human Retroviruses</i>. <b>13</b> (7): 529–531. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1089%2Faid.1997.13.529">10.1089/aid.1997.13.529</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0889-2229">0889-2229</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/9135870">9135870</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=AIDS+Research+and+Human+Retroviruses&amp;rft.atitle=An+Interactive+Web+Site+Providing+Major+Histocompatibility+Ligand+Predictions%3A+Application+to+HIV+Research&amp;rft.volume=13&amp;rft.issue=7&amp;rft.pages=529-531&amp;rft.date=1997-05&amp;rft.issn=0889-2229&amp;rft_id=info%3Apmid%2F9135870&amp;rft_id=info%3Adoi%2F10.1089%2Faid.1997.13.529&amp;rft.aulast=De+Groot&amp;rft.aufirst=Anne+S.&amp;rft.au=Jesdale%2C+Bill+M.&amp;rft.au=Szu%2C+Evan&amp;rft.au=Schafer%2C+James+R.&amp;rft.au=Chicz%2C+Roman+M.&amp;rft.au=Deocampo%2C+Greg&amp;rft_id=http%3A%2F%2Fwww.liebertpub.com%2Fdoi%2F10.1089%2Faid.1997.13.529&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMoiseGutierrezKibriaMartin2015" class="citation journal cs1">Moise, Leonard; Gutierrez, Andres; Kibria, Farzana; Martin, Rebecca; Tassone, Ryan; Liu, Rui; Terry, Frances; Martin, Bill; De Groot, Anne S (2015-09-02). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4635942">"iVAX: An integrated toolkit for the selection and optimization of antigens and the design of epitope-driven vaccines"</a>. <i>Human Vaccines &amp; Immunotherapeutics</i>. <b>11</b> (9): 2312–2321. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F21645515.2015.1061159">10.1080/21645515.2015.1061159</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/2164-5515">2164-5515</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4635942">4635942</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/26155959">26155959</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Human+Vaccines+%26+Immunotherapeutics&amp;rft.atitle=iVAX%3A+An+integrated+toolkit+for+the+selection+and+optimization+of+antigens+and+the+design+of+epitope-driven+vaccines&amp;rft.volume=11&amp;rft.issue=9&amp;rft.pages=2312-2321&amp;rft.date=2015-09-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4635942%23id-name%3DPMC&amp;rft.issn=2164-5515&amp;rft_id=info%3Apmid%2F26155959&amp;rft_id=info%3Adoi%2F10.1080%2F21645515.2015.1061159&amp;rft.aulast=Moise&amp;rft.aufirst=Leonard&amp;rft.au=Gutierrez%2C+Andres&amp;rft.au=Kibria%2C+Farzana&amp;rft.au=Martin%2C+Rebecca&amp;rft.au=Tassone%2C+Ryan&amp;rft.au=Liu%2C+Rui&amp;rft.au=Terry%2C+Frances&amp;rft.au=Martin%2C+Bill&amp;rft.au=De+Groot%2C+Anne+S&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4635942&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFDoBernard2006" class="citation cs2">Do, Quoc-Tuan; Bernard, Philippe (2006), <a rel="nofollow" class="external text" href="https://dx.doi.org/10.1016/s1572-557x(05)02001-5">"Reverse pharmacognosy: a new concept for accelerating natural drug discovery"</a>, <i>Lead Molecules from Natural Products - Discovery and New Trends</i>, Advances in Phytomedicine, Elsevier, vol.&#160;2, pp.&#160;1–20, <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs1572-557x%2805%2902001-5">10.1016/s1572-557x(05)02001-5</a>, <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780444516190" title="Special:BookSources/9780444516190"><bdi>9780444516190</bdi></a><span class="reference-accessdate">, retrieved <span class="nowrap">2021-11-28</span></span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lead+Molecules+from+Natural+Products+-+Discovery+and+New+Trends&amp;rft.atitle=Reverse+pharmacognosy%3A+a+new+concept+for+accelerating+natural+drug+discovery&amp;rft.volume=2&amp;rft.pages=1-20&amp;rft.date=2006&amp;rft_id=info%3Adoi%2F10.1016%2Fs1572-557x%2805%2902001-5&amp;rft.isbn=9780444516190&amp;rft.aulast=Do&amp;rft.aufirst=Quoc-Tuan&amp;rft.au=Bernard%2C+Philippe&amp;rft_id=http%3A%2F%2Fdx.doi.org%2F10.1016%2Fs1572-557x%2805%2902001-5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-:1-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-:1_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:1_20-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:1_20-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:1_20-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.greenpharma.com/products/compound-librairies/">"Compound Librairies"</a>. <i>Greenpharma</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2021-11-27</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Greenpharma&amp;rft.atitle=Compound+Librairies&amp;rft_id=https%3A%2F%2Fwww.greenpharma.com%2Fproducts%2Fcompound-librairies%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.greenpharma.com/pharmacy/drug-discovery/">"Drug discovery"</a>. <i>Greenpharma</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2021-11-28</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Greenpharma&amp;rft.atitle=Drug+discovery&amp;rft_id=https%3A%2F%2Fwww.greenpharma.com%2Fpharmacy%2Fdrug-discovery%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFTakenaka2001" class="citation journal cs1">Takenaka, T. (September 2001). <a rel="nofollow" class="external text" href="https://onlinelibrary.wiley.com/doi/10.1111/j.1464-410X.2001.00112.x">"Classical vs reverse pharmacology in drug discovery"</a>. <i>BJU International</i>. <b>88</b>: 7–10. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1464-410X.2001.00112.x">10.1111/j.1464-410X.2001.00112.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/11589663">11589663</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:30711746">30711746</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BJU+International&amp;rft.atitle=Classical+vs+reverse+pharmacology+in+drug+discovery&amp;rft.volume=88&amp;rft.pages=7-10&amp;rft.date=2001-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A30711746%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F11589663&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1464-410X.2001.00112.x&amp;rft.aulast=Takenaka&amp;rft.aufirst=T.&amp;rft_id=https%3A%2F%2Fonlinelibrary.wiley.com%2Fdoi%2F10.1111%2Fj.1464-410X.2001.00112.x&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-:2-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-:2_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:2_23-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:2_23-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFPinziRastelli2019" class="citation journal cs1">Pinzi, Luca; Rastelli, Giulio (2019-09-04). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6769923">"Molecular Docking: Shifting Paradigms in Drug Discovery"</a>. <i>International Journal of Molecular Sciences</i>. <b>20</b> (18): 4331. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fijms20184331">10.3390/ijms20184331</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1422-0067">1422-0067</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6769923">6769923</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/31487867">31487867</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Molecular+Sciences&amp;rft.atitle=Molecular+Docking%3A+Shifting+Paradigms+in+Drug+Discovery&amp;rft.volume=20&amp;rft.issue=18&amp;rft.pages=4331&amp;rft.date=2019-09-04&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6769923%23id-name%3DPMC&amp;rft.issn=1422-0067&amp;rft_id=info%3Apmid%2F31487867&amp;rft_id=info%3Adoi%2F10.3390%2Fijms20184331&amp;rft.aulast=Pinzi&amp;rft.aufirst=Luca&amp;rft.au=Rastelli%2C+Giulio&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6769923&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKumarKumar2019" class="citation cs2">Kumar, Shivani; Kumar, Suresh (2019), <a rel="nofollow" class="external text" href="https://dx.doi.org/10.1016/b978-0-12-816125-8.00006-7">"Molecular Docking: A Structure-Based Approach for Drug Repurposing"</a>, <i>In Silico Drug Design</i>, Elsevier, pp.&#160;161–189, <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fb978-0-12-816125-8.00006-7">10.1016/b978-0-12-816125-8.00006-7</a>, <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9780128161258" title="Special:BookSources/9780128161258"><bdi>9780128161258</bdi></a>, <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:104470250">104470250</a><span class="reference-accessdate">, retrieved <span class="nowrap">2021-11-28</span></span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=In+Silico+Drug+Design&amp;rft.atitle=Molecular+Docking%3A+A+Structure-Based+Approach+for+Drug+Repurposing&amp;rft.pages=161-189&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A104470250%23id-name%3DS2CID&amp;rft_id=info%3Adoi%2F10.1016%2Fb978-0-12-816125-8.00006-7&amp;rft.isbn=9780128161258&amp;rft.aulast=Kumar&amp;rft.aufirst=Shivani&amp;rft.au=Kumar%2C+Suresh&amp;rft_id=http%3A%2F%2Fdx.doi.org%2F10.1016%2Fb978-0-12-816125-8.00006-7&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://dock.compbio.ucsf.edu/Overview_of_DOCK/index.htm">"Overview of DOCK"</a>. <i>dock.compbio.ucsf.edu</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2021-11-28</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=dock.compbio.ucsf.edu&amp;rft.atitle=Overview+of+DOCK&amp;rft_id=http%3A%2F%2Fdock.compbio.ucsf.edu%2FOverview_of_DOCK%2Findex.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://mondale.ucsf.edu/index_main_frame.html">"Christophe&amp;Genia Guilbert web's page"</a>. <i>mondale.ucsf.edu</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2021-11-28</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=mondale.ucsf.edu&amp;rft.atitle=Christophe%26Genia+Guilbert+web%27s+page&amp;rft_id=http%3A%2F%2Fmondale.ucsf.edu%2Findex_main_frame.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text">D.A. Case, H.M. Aktulga, K. Belfon, I.Y. Ben-Shalom, S.R. Brozell, D.S. Cerutti, T.E. Cheatham, III, G.A. Cisneros, V.W.D. Cruzeiro, T.A. Darden, R.E. Duke, G. Giambasu, M.K. Gilson, H. Gohlke, A.W. Goetz, R. Harris, S. Izadi, S.A. Izmailov, C. Jin, K. Kasavajhala, M.C. Kaymak, E. King, A. Kovalenko, T. Kurtzman, T.S. Lee, S. LeGrand, P. Li, C. Lin, J. Liu, T. Luchko, R. Luo, M. Machado, V. Man, M. Manathunga, K.M. Merz, Y. Miao, O. Mikhailovskii, G. Monard, H. Nguyen, K.A. O’Hearn, A. Onufriev, F. Pan, S. Pantano, R. Qi, A. Rahnamoun, D.R. Roe, A. Roitberg, C. Sagui, S. Schott-Verdugo, J. Shen, C.L. Simmerling, N.R. Skrynnikov, J. Smith, J. Swails, R.C. Walker, J. Wang, H. Wei, R.M. Wolf, X. Wu, Y. Xue, D.M. York, S. Zhao, and P.A. Kollman (2021), <a rel="nofollow" class="external text" href="https://ambermd.org/doc12/Amber21.pdf">Amber 2021</a>, University of California, San Francisco.</span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKharkarWarrierGaud2014" class="citation journal cs1">Kharkar, Prashant S; Warrier, Sona; Gaud, Ram S (March 2014). <a rel="nofollow" class="external text" href="https://dx.doi.org/10.4155/fmc.13.207">"Reverse docking: a powerful tool for drug repositioning and drug rescue"</a>. <i>Future Medicinal Chemistry</i>. <b>6</b> (3): 333–342. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.4155%2Ffmc.13.207">10.4155/fmc.13.207</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1756-8919">1756-8919</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/24575968">24575968</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Future+Medicinal+Chemistry&amp;rft.atitle=Reverse+docking%3A+a+powerful+tool+for+drug+repositioning+and+drug+rescue&amp;rft.volume=6&amp;rft.issue=3&amp;rft.pages=333-342&amp;rft.date=2014-03&amp;rft.issn=1756-8919&amp;rft_id=info%3Apmid%2F24575968&amp;rft_id=info%3Adoi%2F10.4155%2Ffmc.13.207&amp;rft.aulast=Kharkar&amp;rft.aufirst=Prashant+S&amp;rft.au=Warrier%2C+Sona&amp;rft.au=Gaud%2C+Ram+S&amp;rft_id=http%3A%2F%2Fdx.doi.org%2F10.4155%2Ffmc.13.207&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLeeLeeKim2016" class="citation journal cs1">Lee, Aeri; Lee, Kyoungyeul; Kim, Dongsup (2016-07-02). <a rel="nofollow" class="external text" href="https://doi.org/10.1080/17460441.2016.1190706">"Using reverse docking for target identification and its applications for drug discovery"</a>. <i>Expert Opinion on Drug Discovery</i>. <b>11</b> (7): 707–715. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F17460441.2016.1190706">10.1080/17460441.2016.1190706</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1746-0441">1746-0441</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27186904">27186904</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:35165729">35165729</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opinion+on+Drug+Discovery&amp;rft.atitle=Using+reverse+docking+for+target+identification+and+its+applications+for+drug+discovery&amp;rft.volume=11&amp;rft.issue=7&amp;rft.pages=707-715&amp;rft.date=2016-07-02&amp;rft.issn=1746-0441&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A35165729%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27186904&amp;rft_id=info%3Adoi%2F10.1080%2F17460441.2016.1190706&amp;rft.aulast=Lee&amp;rft.aufirst=Aeri&amp;rft.au=Lee%2C+Kyoungyeul&amp;rft.au=Kim%2C+Dongsup&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1080%2F17460441.2016.1190706&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://bidd.group/group/softwares/invdock.htm">"Bioinformatics &amp; Drug Design group &#91;BIDD&#93;"</a>. <i>bidd.group</i><span class="reference-accessdate">. Retrieved <span class="nowrap">2021-11-28</span></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=bidd.group&amp;rft.atitle=Bioinformatics+%26+Drug+Design+group+%5BBIDD%5D&amp;rft_id=http%3A%2F%2Fbidd.group%2Fgroup%2Fsoftwares%2Finvdock.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-:3-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-:3_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:3_31-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFLeeLeeKim2016" class="citation journal cs1">Lee, Aeri; Lee, Kyoungyeul; Kim, Dongsup (June 2016). <a rel="nofollow" class="external text" href="http://www.tandfonline.com/action/showCitFormats?doi=10.1080/17460441.2016.1190706">"Using reverse docking for target identification and its applications for drug discovery"</a>. <i>Expert Opinion on Drug Discovery</i>. <b>11</b> (7): 707–715. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F17460441.2016.1190706">10.1080/17460441.2016.1190706</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1746-0441">1746-0441</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/27186904">27186904</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:35165729">35165729</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opinion+on+Drug+Discovery&amp;rft.atitle=Using+reverse+docking+for+target+identification+and+its+applications+for+drug+discovery&amp;rft.volume=11&amp;rft.issue=7&amp;rft.pages=707-715&amp;rft.date=2016-06&amp;rft.issn=1746-0441&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A35165729%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27186904&amp;rft_id=info%3Adoi%2F10.1080%2F17460441.2016.1190706&amp;rft.aulast=Lee&amp;rft.aufirst=Aeri&amp;rft.au=Lee%2C+Kyoungyeul&amp;rft.au=Kim%2C+Dongsup&amp;rft_id=http%3A%2F%2Fwww.tandfonline.com%2Faction%2FshowCitFormats%3Fdoi%3D10.1080%2F17460441.2016.1190706&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFSaikiaBordoloi2019" class="citation journal cs1">Saikia, Surovi; Bordoloi, Manobjyoti (2019-03-05). <a rel="nofollow" class="external text" href="http://www.eurekaselect.com/166524/article">"Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective"</a>. <i>Current Drug Targets</i>. <b>20</b> (5): 501–521. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F1389450119666181022153016">10.2174/1389450119666181022153016</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30360733">30360733</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:53095334">53095334</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Drug+Targets&amp;rft.atitle=Molecular+Docking%3A+Challenges%2C+Advances+and+its+Use+in+Drug+Discovery+Perspective&amp;rft.volume=20&amp;rft.issue=5&amp;rft.pages=501-521&amp;rft.date=2019-03-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A53095334%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F30360733&amp;rft_id=info%3Adoi%2F10.2174%2F1389450119666181022153016&amp;rft.aulast=Saikia&amp;rft.aufirst=Surovi&amp;rft.au=Bordoloi%2C+Manobjyoti&amp;rft_id=http%3A%2F%2Fwww.eurekaselect.com%2F166524%2Farticle&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-:5-33"><span class="mw-cite-backlink">^ <a href="#cite_ref-:5_33-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:5_33-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:5_33-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:5_33-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFTropshaWang2007" class="citation cs2 cs1-prop-long-vol">Tropsha, A.; Wang, S. X. (2007),  Bourne, H.; Horuk, R.; Kuhnke, J.; Michel, H. (eds.), <a rel="nofollow" class="external text" href="http://link.springer.com/10.1007/2789_2006_003">"QSAR Modeling of GPCR Ligands: Methodologies and Examples of Applications"</a>, <i>GPCRs: From Deorphanization to Lead Structure Identification</i>, Berlin, Heidelberg: Springer Berlin Heidelberg, vol.&#160;2006/2, no.&#160;2, pp.&#160;49–74, <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2F2789_2006_003">10.1007/2789_2006_003</a>, <a href="/wiki/ISBN_(identifier)" class="mw-redirect" title="ISBN (identifier)">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-3-540-48981-8" title="Special:BookSources/978-3-540-48981-8"><bdi>978-3-540-48981-8</bdi></a>, <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17703577">17703577</a><span class="reference-accessdate">, retrieved <span class="nowrap">2021-12-07</span></span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=GPCRs%3A+From+Deorphanization+to+Lead+Structure+Identification&amp;rft.atitle=QSAR+Modeling+of+GPCR+Ligands%3A+Methodologies+and+Examples+of+Applications&amp;rft.volume=2006%2F2&amp;rft.issue=2&amp;rft.pages=49-74&amp;rft.date=2007&amp;rft_id=info%3Apmid%2F17703577&amp;rft_id=info%3Adoi%2F10.1007%2F2789_2006_003&amp;rft.isbn=978-3-540-48981-8&amp;rft.aulast=Tropsha&amp;rft.aufirst=A.&amp;rft.au=Wang%2C+S.+X.&amp;rft_id=http%3A%2F%2Flink.springer.com%2F10.1007%2F2789_2006_003&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFKutzlebBusmannWendlandMaronde2005" class="citation journal cs1">Kutzleb, Christian; Busmann, Annette; Wendland, Martin; Maronde, Erik (2005-06-01). <a rel="nofollow" class="external text" href="https://dx.doi.org/10.2174/1389203054065419">"Discovery of Novel Regulatory Peptides by Reverse Pharmacology: Spotlight on Chemerin and the RF-amide Peptides Metastin and QRFP"</a>. <i>Current Protein &amp; Peptide Science</i>. <b>6</b> (3): 265–278. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F1389203054065419">10.2174/1389203054065419</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1389-2037">1389-2037</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/15974952">15974952</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Protein+%26+Peptide+Science&amp;rft.atitle=Discovery+of+Novel+Regulatory+Peptides+by+Reverse+Pharmacology%3A+Spotlight+on+Chemerin+and+the+RF-amide+Peptides+Metastin+and+QRFP&amp;rft.volume=6&amp;rft.issue=3&amp;rft.pages=265-278&amp;rft.date=2005-06-01&amp;rft.issn=1389-2037&amp;rft_id=info%3Apmid%2F15974952&amp;rft_id=info%3Adoi%2F10.2174%2F1389203054065419&amp;rft.aulast=Kutzleb&amp;rft.aufirst=Christian&amp;rft.au=Busmann%2C+Annette&amp;rft.au=Wendland%2C+Martin&amp;rft.au=Maronde%2C+Erik&amp;rft_id=http%3A%2F%2Fdx.doi.org%2F10.2174%2F1389203054065419&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFCivelliSaitoWangNothacker2006" class="citation journal cs1">Civelli, Olivier; Saito, Yumiko; Wang, Zhiwei; Nothacker, Hans-Peter; Reinscheid, Rainer K. (2006-06-01). <a rel="nofollow" class="external text" href="https://www.sciencedirect.com/science/article/pii/S0163725805002123">"Orphan GPCRs and their ligands"</a>. <i>Pharmacology &amp; Therapeutics</i>. New Developments in Receptor Pharmacology. <b>110</b> (3): 525–532. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.pharmthera.2005.10.001">10.1016/j.pharmthera.2005.10.001</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0163-7258">0163-7258</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacology+%26+Therapeutics&amp;rft.atitle=Orphan+GPCRs+and+their+ligands&amp;rft.volume=110&amp;rft.issue=3&amp;rft.pages=525-532&amp;rft.date=2006-06-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.pharmthera.2005.10.001&amp;rft.issn=0163-7258&amp;rft.aulast=Civelli&amp;rft.aufirst=Olivier&amp;rft.au=Saito%2C+Yumiko&amp;rft.au=Wang%2C+Zhiwei&amp;rft.au=Nothacker%2C+Hans-Peter&amp;rft.au=Reinscheid%2C+Rainer+K.&amp;rft_id=https%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0163725805002123&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fbph.14748">10.1111/bph.14748 </a></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFVanderheydenTirupulaThomasStorjohann2020" class="citation journal cs1">Vanderheyden, Patrick; Tirupula, Kalyan; Thomas, Walter G.; Storjohann, Laura; Stoddart, Leigh; Spindel, Eliot; Spedding, Michael; Sharman, Joanna L.; Pin, Jean-Philippe; Pawson, Adam J.; Neubig, Richard; Mpamhanga, Chido; Monaghan, Amy E.; Liew, Wen Chiy; Kostenis, Evi; Karnik, Sadashiva; Jensen, Robert T.; Holliday, Nick; Harmar, Anthony; Eguchi, Satoru; Dhanachandra Singh, Khuraijam; Davenport, Anthony P.; Bonner, Tom I.; Benya, Richard V.; Benson, Helen E.; Battey, Jim; Alexander, Stephen P.H. (2020). "Class a Orphans (Version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database". <i>IUPHAR/BPS Guide to Pharmacology Cite</i>. <b>2020</b> (5). <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2218%2Fgtopdb%2FF16%2F2020.5">10.2218/gtopdb/F16/2020.5</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:228927632">228927632</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=IUPHAR%2FBPS+Guide+to+Pharmacology+Cite&amp;rft.atitle=Class+a+Orphans+%28Version+2020.5%29+in+the+IUPHAR%2FBPS+Guide+to+Pharmacology+Database&amp;rft.volume=2020&amp;rft.issue=5&amp;rft.date=2020&amp;rft_id=info%3Adoi%2F10.2218%2Fgtopdb%2FF16%2F2020.5&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A228927632%23id-name%3DS2CID&amp;rft.aulast=Vanderheyden&amp;rft.aufirst=Patrick&amp;rft.au=Tirupula%2C+Kalyan&amp;rft.au=Thomas%2C+Walter+G.&amp;rft.au=Storjohann%2C+Laura&amp;rft.au=Stoddart%2C+Leigh&amp;rft.au=Spindel%2C+Eliot&amp;rft.au=Spedding%2C+Michael&amp;rft.au=Sharman%2C+Joanna+L.&amp;rft.au=Pin%2C+Jean-Philippe&amp;rft.au=Pawson%2C+Adam+J.&amp;rft.au=Neubig%2C+Richard&amp;rft.au=Mpamhanga%2C+Chido&amp;rft.au=Monaghan%2C+Amy+E.&amp;rft.au=Liew%2C+Wen+Chiy&amp;rft.au=Kostenis%2C+Evi&amp;rft.au=Karnik%2C+Sadashiva&amp;rft.au=Jensen%2C+Robert+T.&amp;rft.au=Holliday%2C+Nick&amp;rft.au=Harmar%2C+Anthony&amp;rft.au=Eguchi%2C+Satoru&amp;rft.au=Dhanachandra+Singh%2C+Khuraijam&amp;rft.au=Davenport%2C+Anthony+P.&amp;rft.au=Bonner%2C+Tom+I.&amp;rft.au=Benya%2C+Richard+V.&amp;rft.au=Benson%2C+Helen+E.&amp;rft.au=Battey%2C+Jim&amp;rft.au=Alexander%2C+Stephen+P.H.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFXuWolfrumUshkaryovStacey2019" class="citation journal cs1">Xu, Lei; Wolfrum, Uwe; Ushkaryov, Yuri; Stacey, Martin; Singer, Kathleen; Schiöth, Helgi; Schöneberg, Torsten; Prömel, Simone; Piao, Xianhua; Monk, Kelly; Martinelli, David C.; Lin, Hsi-Hsien; Le Duc, Diana; Langenhan, Tobias; Krishnan, Arunkumar; Knapp, Barbara; Kirchhoff, Christiane; Heyne, Henrike; Harty, Breanne; Hamann, Jörg; Formstone, Caroline; Cappallo-Obermann, Heike; Bonner, Tom I.; Aust, Gabriela; Arac-Ozkan, Demet (2019). "Adhesion Class GPCRS (Version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database". <i>IUPHAR/BPS Guide to Pharmacology Cite</i>. <b>2019</b> (4). <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2218%2Fgtopdb%2FF17%2F2019.4">10.2218/gtopdb/F17/2019.4</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:203707503">203707503</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=IUPHAR%2FBPS+Guide+to+Pharmacology+Cite&amp;rft.atitle=Adhesion+Class+GPCRS+%28Version+2019.4%29+in+the+IUPHAR%2FBPS+Guide+to+Pharmacology+Database&amp;rft.volume=2019&amp;rft.issue=4&amp;rft.date=2019&amp;rft_id=info%3Adoi%2F10.2218%2Fgtopdb%2FF17%2F2019.4&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A203707503%23id-name%3DS2CID&amp;rft.aulast=Xu&amp;rft.aufirst=Lei&amp;rft.au=Wolfrum%2C+Uwe&amp;rft.au=Ushkaryov%2C+Yuri&amp;rft.au=Stacey%2C+Martin&amp;rft.au=Singer%2C+Kathleen&amp;rft.au=Schi%C3%B6th%2C+Helgi&amp;rft.au=Sch%C3%B6neberg%2C+Torsten&amp;rft.au=Pr%C3%B6mel%2C+Simone&amp;rft.au=Piao%2C+Xianhua&amp;rft.au=Monk%2C+Kelly&amp;rft.au=Martinelli%2C+David+C.&amp;rft.au=Lin%2C+Hsi-Hsien&amp;rft.au=Le+Duc%2C+Diana&amp;rft.au=Langenhan%2C+Tobias&amp;rft.au=Krishnan%2C+Arunkumar&amp;rft.au=Knapp%2C+Barbara&amp;rft.au=Kirchhoff%2C+Christiane&amp;rft.au=Heyne%2C+Henrike&amp;rft.au=Harty%2C+Breanne&amp;rft.au=Hamann%2C+J%C3%B6rg&amp;rft.au=Formstone%2C+Caroline&amp;rft.au=Cappallo-Obermann%2C+Heike&amp;rft.au=Bonner%2C+Tom+I.&amp;rft.au=Aust%2C+Gabriela&amp;rft.au=Arac-Ozkan%2C+Demet&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFShobackConigraveBrownBräuner-Osborne2019" class="citation journal cs1">Shoback, Dolores; Conigrave, Arthur; Brown, Edward M.; Bräuner-Osborne, Hans; Bikle, Daniel (2019). "Class C Orphans (Version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database". <i>IUPHAR/BPS Guide to Pharmacology Cite</i>. <b>2019</b> (4). <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2218%2Fgtopdb%2FF18%2F2019.4">10.2218/gtopdb/F18/2019.4</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:203705510">203705510</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=IUPHAR%2FBPS+Guide+to+Pharmacology+Cite&amp;rft.atitle=Class+C+Orphans+%28Version+2019.4%29+in+the+IUPHAR%2FBPS+Guide+to+Pharmacology+Database&amp;rft.volume=2019&amp;rft.issue=4&amp;rft.date=2019&amp;rft_id=info%3Adoi%2F10.2218%2Fgtopdb%2FF18%2F2019.4&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A203705510%23id-name%3DS2CID&amp;rft.aulast=Shoback&amp;rft.aufirst=Dolores&amp;rft.au=Conigrave%2C+Arthur&amp;rft.au=Brown%2C+Edward+M.&amp;rft.au=Br%C3%A4uner-Osborne%2C+Hans&amp;rft.au=Bikle%2C+Daniel&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMorfaBassoniSzaboMcAnally2018" class="citation journal cs1">Morfa, Camilo J.; Bassoni, Daniel; Szabo, Andras; McAnally, Danielle; Sharir, Haleli; Hood, Becky L.; Vasile, Stefan; Wehrman, Tom; Lamerdin, Jane; Smith, Layton H. (October 2018). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6207161">"A Pharmacochaperone-Based High-Throughput Screening Assay for the Discovery of Chemical Probes of Orphan Receptors"</a>. <i>ASSAY and Drug Development Technologies</i>. <b>16</b> (7): 384–396. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1089%2Fadt.2018.868">10.1089/adt.2018.868</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/1540-658X">1540-658X</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC6207161">6207161</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/30251873">30251873</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=ASSAY+and+Drug+Development+Technologies&amp;rft.atitle=A+Pharmacochaperone-Based+High-Throughput+Screening+Assay+for+the+Discovery+of+Chemical+Probes+of+Orphan+Receptors&amp;rft.volume=16&amp;rft.issue=7&amp;rft.pages=384-396&amp;rft.date=2018-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6207161%23id-name%3DPMC&amp;rft.issn=1540-658X&amp;rft_id=info%3Apmid%2F30251873&amp;rft_id=info%3Adoi%2F10.1089%2Fadt.2018.868&amp;rft.aulast=Morfa&amp;rft.aufirst=Camilo+J.&amp;rft.au=Bassoni%2C+Daniel&amp;rft.au=Szabo%2C+Andras&amp;rft.au=McAnally%2C+Danielle&amp;rft.au=Sharir%2C+Haleli&amp;rft.au=Hood%2C+Becky+L.&amp;rft.au=Vasile%2C+Stefan&amp;rft.au=Wehrman%2C+Tom&amp;rft.au=Lamerdin%2C+Jane&amp;rft.au=Smith%2C+Layton+H.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6207161&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1067248974"/><cite id="CITEREFMieda2002" class="citation journal cs1">Mieda, M (2002-06-01). <a rel="nofollow" class="external text" href="https://dx.doi.org/10.1016/s0959-4388(02)00331-8">"Sleep, feeding, and neuropeptides: roles of orexins and orexin receptors"</a>. <i>Current Opinion in Neurobiology</i>. <b>12</b> (3): 339–345. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fs0959-4388%2802%2900331-8">10.1016/s0959-4388(02)00331-8</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0959-4388">0959-4388</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/12049942">12049942</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:35147196">35147196</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Neurobiology&amp;rft.atitle=Sleep%2C+feeding%2C+and+neuropeptides%3A+roles+of+orexins+and+orexin+receptors&amp;rft.volume=12&amp;rft.issue=3&amp;rft.pages=339-345&amp;rft.date=2002-06-01&amp;rft.issn=0959-4388&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A35147196%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12049942&amp;rft_id=info%3Adoi%2F10.1016%2Fs0959-4388%2802%2900331-8&amp;rft.aulast=Mieda&amp;rft.aufirst=M&amp;rft_id=http%3A%2F%2Fdx.doi.org%2F10.1016%2Fs0959-4388%2802%2900331-8&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AReverse+pharmacology" class="Z3988"></span></span>
</li>
</ol></div>
<div class="navbox-styles nomobile"><style data-mw-deduplicate="TemplateStyles:r1061467846">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style></div><div role="navigation" class="navbox" aria-labelledby="Pharmacology" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><style data-mw-deduplicate="TemplateStyles:r1063604349">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Pharmacology" title="Template:Pharmacology"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Pharmacology" title="Template talk:Pharmacology"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Pharmacology&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Pharmacology" style="font-size:114%;margin:0 4em"><a href="/wiki/Pharmacology" title="Pharmacology">Pharmacology</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center;"><a href="/wiki/Ligand_(biochemistry)" title="Ligand (biochemistry)">Ligand (biochemistry)</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Excitatory" scope="row" class="navbox-group" style="width:1%;text-align: center;">Excitatory</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Agonist" title="Agonist">Agonist</a></li>
<li><a href="/wiki/Endogenous_agonist" title="Endogenous agonist">Endogenous agonist</a></li>
<li><a href="/wiki/Irreversible_agonist" title="Irreversible agonist">Irreversible agonist</a></li>
<li><a href="/wiki/Partial_agonist" title="Partial agonist">Partial agonist</a></li>
<li><a href="/wiki/Superagonist" title="Superagonist">Superagonist</a></li>
<li><a href="/wiki/Physiological_agonism_and_antagonism" title="Physiological agonism and antagonism">Physiological agonist</a></li></ul>
</div></td></tr></tbody></table><div>
  </div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Inhibitory" scope="row" class="navbox-group" style="width:1%;text-align: center;">Inhibitory</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Receptor_antagonist" title="Receptor antagonist">Antagonist</a></li>
<li><a href="/wiki/Competitive_antagonist" class="mw-redirect" title="Competitive antagonist">Competitive antagonist</a></li>
<li><a href="/wiki/Irreversible_antagonist" title="Irreversible antagonist">Irreversible antagonist</a></li>
<li><a href="/wiki/Physiological_agonism_and_antagonism" title="Physiological agonism and antagonism">Physiological antagonist</a></li>
<li><a href="/wiki/Inverse_agonist" title="Inverse agonist">Inverse agonist</a></li>
<li><a href="/wiki/Enzyme_inhibitor" title="Enzyme inhibitor">Enzyme inhibitor</a></li></ul>
</div></td></tr></tbody></table><div>
<ul><li><a href="/wiki/Drug" title="Drug">Drug</a></li>
<li><a href="/wiki/Neurotransmitter" title="Neurotransmitter">Neurotransmitter</a></li>
<li><a href="/wiki/Agonist-antagonist" title="Agonist-antagonist">Agonist-antagonist</a></li>
<li><a href="/wiki/Pharmacophore" title="Pharmacophore">Pharmacophore</a></li></ul></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center;"><a href="/wiki/Pharmacodynamics" title="Pharmacodynamics">Pharmacodynamics</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Activity_at_receptor" scope="row" class="navbox-group" style="width:1%;text-align: center;">Activity at receptor</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<li><a href="/wiki/Mechanism_of_action" title="Mechanism of action">Mechanism of action</a></li>
<li><a href="/wiki/Mode_of_action" title="Mode of action">Mode of action</a></li>
<li><a href="/wiki/Molecular_binding" title="Molecular binding">Binding</a></li>
<li><a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">Receptor (biochemistry)</a></li>
<li><a href="/wiki/Desensitization_(pharmacology)" class="mw-redirect" title="Desensitization (pharmacology)">Desensitization (pharmacology)</a></li>
</div></td></tr></tbody></table><div>
    </div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Other_effects_of_ligand" scope="row" class="navbox-group" style="width:1%;text-align: center;">Other effects of ligand</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li>Selectivity (<a href="/wiki/Binding_selectivity" title="Binding selectivity">Binding</a>, <a href="/wiki/Functional_selectivity" title="Functional selectivity">Functional</a>)</li>
<li><a href="/wiki/Pleiotropy_(drugs)" title="Pleiotropy (drugs)">Pleiotropy (drugs)</a></li>
<li><a href="/wiki/Non-specific_effect_of_vaccines" title="Non-specific effect of vaccines">Non-specific effect of vaccines</a></li>
<li><a href="/wiki/Adverse_effects" class="mw-redirect" title="Adverse effects">Adverse effects</a></li>
<li><a href="/wiki/Toxicity" title="Toxicity">Toxicity</a> (<a href="/wiki/Neurotoxicity" title="Neurotoxicity">Neurotoxicity</a>)</li></ul>
</div></td></tr></tbody></table><div>
    </div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Analysis" scope="row" class="navbox-group" style="width:1%;text-align: center;">Analysis</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Dose%E2%80%93response_relationship" title="Dose–response relationship">Dose–response relationship</a></li>
<li><a href="/wiki/Hill_equation_(biochemistry)" title="Hill equation (biochemistry)">Hill equation (biochemistry)</a></li>
<li><a href="/wiki/Schild_plot" class="mw-redirect" title="Schild plot">Schild plot</a></li>
<li><a href="/wiki/Del_Castillo_Katz_model" class="mw-redirect" title="Del Castillo Katz model">Del Castillo Katz model</a></li>
<li><a href="/wiki/Cheng-Prussoff_Equation" class="mw-redirect" title="Cheng-Prussoff Equation">Cheng-Prussoff Equation</a></li>
<li>Methods (<a href="/wiki/Organ_bath" title="Organ bath">Organ bath</a>, <a href="/wiki/Ligand_binding_assay" title="Ligand binding assay">Ligand binding assay</a>, <a href="/wiki/Patch-clamp" class="mw-redirect" title="Patch-clamp">Patch-clamp</a>)</li></ul>
</div></td></tr></tbody></table><div>
    </div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Metrics" scope="row" class="navbox-group" style="width:1%;text-align: center;">Metrics</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Efficacy#Pharmacology" title="Efficacy">Efficacy</a></li>
<li><a href="/wiki/Intrinsic_activity" title="Intrinsic activity">Intrinsic activity</a></li>
<li><a href="/wiki/Potency_(pharmacology)" title="Potency (pharmacology)">Potency</a> (<a href="/wiki/EC50" title="EC50">EC50</a>, <a href="/wiki/IC50" title="IC50">IC50</a>, <a href="/wiki/Effective_dose_(pharmacology)" title="Effective dose (pharmacology)">ED50</a>, <a href="/wiki/Median_lethal_dose" title="Median lethal dose">LD50</a>, <a href="/wiki/Median_toxic_dose" title="Median toxic dose">TD50</a>)</li>
<li><a href="/wiki/Therapeutic_index" title="Therapeutic index">Therapeutic index</a></li>
<li><a href="/wiki/Dissociation_constant#Protein-ligand_binding" title="Dissociation constant">Affinity</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center;"><a href="/wiki/Pharmacokinetics" title="Pharmacokinetics">Pharmacokinetics</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Metrics" scope="row" class="navbox-group" style="width:1%;text-align: center;">Metrics</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Loading_dose" title="Loading dose">Loading dose</a></li>
<li><a href="/wiki/Volume_of_distribution" title="Volume of distribution">Volume of distribution</a> (<a href="/wiki/Initial_volume_of_distribution" title="Initial volume of distribution">Initial</a>)</li>
<li><a href="/wiki/Rate_of_infusion" title="Rate of infusion">Rate of infusion</a></li>
<li><a href="/wiki/Onset_of_action" title="Onset of action">Onset of action</a></li>
<li><a href="/wiki/Biological_half-life" title="Biological half-life">Biological half-life</a></li>
<li><a href="/wiki/Plasma_protein_binding" title="Plasma protein binding">Plasma protein binding</a></li>
<li><a href="/wiki/Bioavailability" title="Bioavailability">Bioavailability</a></li></ul>
</div></td></tr></tbody></table><div>
    </div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="LADME" scope="row" class="navbox-group" style="width:1%;text-align: center;">LADME</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/ADME" title="ADME">(L)ADME</a>: (<a href="/wiki/Liberation_(pharmacology)" title="Liberation (pharmacology)">Liberation</a>)</li>
<li><a href="/wiki/Absorption_(pharmacokinetics)" class="mw-redirect" title="Absorption (pharmacokinetics)">Absorption</a></li>
<li><a href="/wiki/Distribution_(pharmacology)" title="Distribution (pharmacology)">Distribution</a></li>
<li><a href="/wiki/Drug_metabolism" title="Drug metabolism">Metabolism</a></li>
<li><a href="/wiki/Excretion" title="Excretion">Excretion</a> (<a href="/wiki/Clearance_(pharmacology)" title="Clearance (pharmacology)">Clearance</a>)</li></ul>
</div></td></tr></tbody></table><div>
<ul><li><a href="/wiki/Compartment_(pharmacokinetics)" title="Compartment (pharmacokinetics)">Compartment</a></li>
<li><a href="/wiki/Bioequivalence" title="Bioequivalence">Bioequivalence</a></li></ul></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center;">Related<br /> fields</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Neuroscience_and_psychology" scope="row" class="navbox-group" style="width:1%;text-align: center;"><a href="/wiki/Neuroscience" title="Neuroscience">Neuroscience</a> and <a href="/wiki/Psychology" title="Psychology">psychology</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<li><a href="/wiki/Neuropsychopharmacology" title="Neuropsychopharmacology">Neuropsychopharmacology</a></li>
<li><a href="/wiki/Neuropharmacology" title="Neuropharmacology">Neuropharmacology</a></li>
<li><a href="/wiki/Psychopharmacology" title="Psychopharmacology">Psychopharmacology</a></li>
<li><a href="/wiki/Electrophysiology" title="Electrophysiology">Electrophysiology</a></li>
</div></td></tr></tbody></table><div>
    </div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Medicine" scope="row" class="navbox-group" style="width:1%;text-align: center;"><a href="/wiki/Medicine" title="Medicine">Medicine</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Clinical_pharmacology" title="Clinical pharmacology">Clinical pharmacology</a></li>
<li><a href="/wiki/Pharmacy" title="Pharmacy">Pharmacy</a></li>
<li><a href="/wiki/Medicinal_chemistry" title="Medicinal chemistry">Medicinal chemistry</a></li>
<li><a href="/wiki/Pharmacoepidemiology" title="Pharmacoepidemiology">Pharmacoepidemiology</a></li></ul>
</div></td></tr></tbody></table><div>
    </div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Biochemistry_and_genetics" scope="row" class="navbox-group" style="width:1%;text-align: center;"><a href="/wiki/Biochemistry" title="Biochemistry">Biochemistry</a> and <a href="/wiki/Genetics" title="Genetics">genetics</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Pharmacoinformatics" title="Pharmacoinformatics">Pharmacoinformatics</a></li>
<li><a href="/wiki/Pharmacogenetics" class="mw-redirect" title="Pharmacogenetics">Pharmacogenetics</a></li>
<li><a href="/wiki/Pharmacogenomics" title="Pharmacogenomics">Pharmacogenomics</a></li></ul>
</div></td></tr></tbody></table><div>
    </div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Toxicology" scope="row" class="navbox-group" style="width:1%;text-align: center;"><a href="/wiki/Toxicology" title="Toxicology">Toxicology</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Pharmacotoxicology" title="Pharmacotoxicology">Pharmacotoxicology</a></li>
<li><a href="/wiki/Neurotoxicology" class="mw-redirect" title="Neurotoxicology">Neurotoxicology</a></li></ul>
</div></td></tr></tbody></table><div>
    </div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Drug_discovery" scope="row" class="navbox-group" style="width:1%;text-align: center;"><a href="/wiki/Drug_discovery" title="Drug discovery">Drug discovery</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Classical_pharmacology" title="Classical pharmacology">Classical pharmacology</a></li>
<li><a class="mw-selflink selflink">Reverse pharmacology</a></li></ul>
</div></td></tr></tbody></table><div>
<ul><li><a href="/wiki/Photopharmacology" title="Photopharmacology">Photopharmacology</a></li>
<li><a href="/wiki/Immunopharmacology" class="mw-redirect" title="Immunopharmacology">Immunopharmacology</a></li>
<li><a href="/wiki/Cell_biology" title="Cell biology">Cell biology</a></li>
<li><a href="/wiki/Physiology" title="Physiology">Physiology</a></li></ul></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;text-align: center;">Other</th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<li><a href="/wiki/Coinduction_(anaesthetics)" class="mw-redirect" title="Coinduction (anaesthetics)">Coinduction (anaesthetics)</a></li>
<li><a href="/wiki/Combination_therapy" title="Combination therapy">Combination therapy</a></li>
<li><a href="/wiki/Functional_analog_(chemistry)" title="Functional analog (chemistry)">Functional analog (chemistry)</a></li>
<li><a href="/wiki/Polypharmacology" title="Polypharmacology">Polypharmacology</a></li>
<li><a href="/wiki/Chemotherapy" title="Chemotherapy">Chemotherapy</a></li>
<li><a href="/wiki/List_of_drugs" class="mw-redirect" title="List of drugs">List of drugs</a></li>
<li><a href="/wiki/WHO_list_of_essential_medicines" class="mw-redirect" title="WHO list of essential medicines">WHO list of essential medicines</a></li>
    </div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Tolerance_and_resistance" scope="row" class="navbox-group" style="width:1%;text-align: center;">Tolerance and resistance</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Drug_tolerance" title="Drug tolerance">Drug tolerance</a></li>
<li><a href="/wiki/Tachyphylaxis" title="Tachyphylaxis">Tachyphylaxis</a></li>
<li><a href="/wiki/Drug_resistance" title="Drug resistance">Drug resistance</a></li>
<li><a href="/wiki/Antibiotic_resistance" class="mw-redirect" title="Antibiotic resistance">Antibiotic resistance</a></li>
<li><a href="/wiki/Multiple_drug_resistance" title="Multiple drug resistance">Multiple drug resistance</a></li></ul>
</div></td></tr></tbody></table><div>
    </div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Antimicrobial_pharmacology" scope="row" class="navbox-group" style="width:1%;text-align: center;">Antimicrobial pharmacology</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Antimicrobial_pharmacodynamics" title="Antimicrobial pharmacodynamics">Antimicrobial pharmacodynamics</a></li>
<li><a href="/wiki/Minimum_inhibitory_concentration" title="Minimum inhibitory concentration">Minimum inhibitory concentration</a></li>
<li><a href="/wiki/Bacteriostatic_agent" title="Bacteriostatic agent">Bacteriostatic</a></li>
<li><a href="/wiki/Minimum_bactericidal_concentration" title="Minimum bactericidal concentration">Minimum bactericidal concentration</a></li>
<li><a href="/wiki/Bactericide" title="Bactericide">Bactericide</a></li></ul>
</div></td></tr></tbody></table><div>
</div></td></tr></tbody></table></div>
<!-- 
NewPP limit report
Parsed by mw1419
Cached time: 20220201071254
Cache expiry: 1814400
Reduced expiry: false
Complications: [vary‐revision‐sha1]
CPU time usage: 0.704 seconds
Real time usage: 0.810 seconds
Preprocessor visited node count: 3226/1000000
Post‐expand include size: 151293/2097152 bytes
Template argument size: 1259/2097152 bytes
Highest expansion depth: 12/100
Expensive parser function count: 2/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 145178/5000000 bytes
Lua time usage: 0.389/10.000 seconds
Lua memory usage: 6169554/52428800 bytes
Number of Wikibase entities loaded: 0/400
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  630.479      1 -total
 58.79%  370.657      1 Template:Reflist
 41.71%  262.949     30 Template:Cite_journal
 18.11%  114.182     16 Template:Navbox
 14.49%   91.364      1 Template:Pharmacology
 10.21%   64.350      1 Template:Short_description
  8.19%   51.629      1 Template:Cn
  6.90%   43.484      1 Template:Fix
  6.14%   38.681      1 Template:Pagetype
  3.98%   25.105      2 Template:Category_handler
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:35290643-0!canonical and timestamp 20220201071253 and revision id 1067674048. Serialized with JSON.
 -->
</div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript>
<div class="printfooter">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Reverse_pharmacology&amp;oldid=1067674048">https://en.wikipedia.org/w/index.php?title=Reverse_pharmacology&amp;oldid=1067674048</a>"</div></div>
		<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Drug_discovery" title="Category:Drug discovery">Drug discovery</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1:_long_volume_value" title="Category:CS1: long volume value">CS1: long volume value</a></li><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_matches_Wikidata" title="Category:Short description matches Wikidata">Short description matches Wikidata</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_December_2021" title="Category:Articles with unsourced statements from December 2021">Articles with unsourced statements from December 2021</a></li></ul></div></div>
	</div>
</div>
<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

<div id="mw-navigation">
	<h2>Navigation menu</h2>
	<div id="mw-head">
		<nav id="p-personal" class="mw-portlet mw-portlet-personal vector-user-menu-legacy vector-menu" aria-labelledby="p-personal-label" role="navigation" 
	 >
	<h3 id="p-personal-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Personal tools</span>
	</h3>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-anonuserpage" class="mw-list-item"><span>Not logged in</span></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n"><span>Talk</span></a></li><li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y"><span>Contributions</span></a></li><li id="pt-createaccount" class="mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Reverse+pharmacology" title="You are encouraged to create an account and log in; however, it is not mandatory"><span>Create account</span></a></li><li id="pt-login" class="mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Reverse+pharmacology" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span>Log in</span></a></li></ul>
		
	</div>
</nav>

		<div id="left-navigation">
			<nav id="p-namespaces" class="mw-portlet mw-portlet-namespaces vector-menu vector-menu-tabs" aria-labelledby="p-namespaces-label" role="navigation" 
	 >
	<h3 id="p-namespaces-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Namespaces</span>
	</h3>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="ca-nstab-main" class="selected mw-list-item"><a href="/wiki/Reverse_pharmacology" title="View the content page [c]" accesskey="c"><span>Article</span></a></li><li id="ca-talk" class="mw-list-item"><a href="/wiki/Talk:Reverse_pharmacology" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t"><span>Talk</span></a></li></ul>
		
	</div>
</nav>

			<nav id="p-variants" class="mw-portlet mw-portlet-variants emptyPortlet vector-menu-dropdown-noicon vector-menu vector-menu-dropdown" aria-labelledby="p-variants-label" role="navigation" 
	 >
	<input type="checkbox"
		id="p-variants-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-variants"
		class="vector-menu-checkbox" aria-labelledby="p-variants-label" />
	<h3 id="p-variants-label" aria-label="Change language variant" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Variants</span>
			<span class="vector-menu-checkbox-expanded">expanded</span>
			<span class="vector-menu-checkbox-collapsed">collapsed</span>
	</h3>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"></ul>
		
	</div>
</nav>

		</div>
		<div id="right-navigation">
			<nav id="p-views" class="mw-portlet mw-portlet-views vector-menu vector-menu-tabs" aria-labelledby="p-views-label" role="navigation" 
	 >
	<h3 id="p-views-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Views</span>
	</h3>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="ca-view" class="selected mw-list-item"><a href="/wiki/Reverse_pharmacology"><span>Read</span></a></li><li id="ca-edit" class="mw-list-item"><a href="/w/index.php?title=Reverse_pharmacology&amp;action=edit" title="Edit this page [e]" accesskey="e"><span>Edit</span></a></li><li id="ca-history" class="mw-list-item"><a href="/w/index.php?title=Reverse_pharmacology&amp;action=history" title="Past revisions of this page [h]" accesskey="h"><span>View history</span></a></li></ul>
		
	</div>
</nav>

			<nav id="p-cactions" class="mw-portlet mw-portlet-cactions emptyPortlet vector-menu-dropdown-noicon vector-menu vector-menu-dropdown" aria-labelledby="p-cactions-label" role="navigation"  title="More options"
	 >
	<input type="checkbox"
		id="p-cactions-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-cactions"
		class="vector-menu-checkbox" aria-labelledby="p-cactions-label" />
	<h3 id="p-cactions-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">More</span>
			<span class="vector-menu-checkbox-expanded">expanded</span>
			<span class="vector-menu-checkbox-collapsed">collapsed</span>
	</h3>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"></ul>
		
	</div>
</nav>

			<div id="p-search" role="search" class=" vector-search-box">
	<div>
			<h3 >
				<label for="searchInput">Search</label>
			</h3>
		<form action="/w/index.php" id="searchform"
			class="vector-search-box-form">
			<div id="simpleSearch"
				class="vector-search-box-inner"
				 data-search-loc="header-navigation">
				<input class="vector-search-box-input"
					 type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput"
				/>
				<input type="hidden" name="title" value="Special:Search"/>
				<input id="mw-searchButton"
					 class="searchButton mw-fallbackSearchButton" type="submit" name="fulltext" title="Search Wikipedia for this text" value="Search" />
				<input id="searchButton"
					 class="searchButton" type="submit" name="go" title="Go to a page with this exact name if it exists" value="Go" />
			</div>
		</form>
	</div>
</div>

		</div>
	</div>
	
<div id="mw-panel">
	<div id="p-logo" role="banner">
		<a class="mw-wiki-logo" href="/wiki/Main_Page"
			title="Visit the main page"></a>
	</div>
	<nav id="p-navigation" class="mw-portlet mw-portlet-navigation vector-menu vector-menu-portal portal" aria-labelledby="p-navigation-label" role="navigation" 
	 >
	<h3 id="p-navigation-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Navigation</span>
	</h3>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"><span>Main page</span></a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia"><span>Contents</span></a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events"><span>Current events</span></a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x"><span>Random article</span></a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works"><span>About Wikipedia</span></a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia"><span>Contact us</span></a></li><li id="n-sitesupport" class="mw-list-item"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us by donating to the Wikimedia Foundation"><span>Donate</span></a></li></ul>
		
	</div>
</nav>

	<nav id="p-interaction" class="mw-portlet mw-portlet-interaction vector-menu vector-menu-portal portal" aria-labelledby="p-interaction-label" role="navigation" 
	 >
	<h3 id="p-interaction-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Contribute</span>
	</h3>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia"><span>Help</span></a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia"><span>Learn to edit</span></a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors"><span>Community portal</span></a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r"><span>Recent changes</span></a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Add images or other media for use on Wikipedia"><span>Upload file</span></a></li></ul>
		
	</div>
</nav>
<nav id="p-tb" class="mw-portlet mw-portlet-tb vector-menu vector-menu-portal portal" aria-labelledby="p-tb-label" role="navigation" 
	 >
	<h3 id="p-tb-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Tools</span>
	</h3>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/Reverse_pharmacology" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j"><span>What links here</span></a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/Reverse_pharmacology" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k"><span>Related changes</span></a></li><li id="t-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u"><span>Upload file</span></a></li><li id="t-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q"><span>Special pages</span></a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=Reverse_pharmacology&amp;oldid=1067674048" title="Permanent link to this revision of this page"><span>Permanent link</span></a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=Reverse_pharmacology&amp;action=info" title="More information about this page"><span>Page information</span></a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Reverse_pharmacology&amp;id=1067674048&amp;wpFormIdentifier=titleform" title="Information on how to cite this page"><span>Cite this page</span></a></li><li id="t-wikibase" class="mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q7318256" title="Structured data on this page hosted by Wikidata [g]" accesskey="g"><span>Wikidata item</span></a></li></ul>
		
	</div>
</nav>
<nav id="p-coll-print_export" class="mw-portlet mw-portlet-coll-print_export vector-menu vector-menu-portal portal" aria-labelledby="p-coll-print_export-label" role="navigation" 
	 >
	<h3 id="p-coll-print_export-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Print/export</span>
	</h3>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&amp;page=Reverse_pharmacology&amp;action=show-download-screen" title="Download this page as a PDF file"><span>Download as PDF</span></a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=Reverse_pharmacology&amp;printable=yes" title="Printable version of this page [p]" accesskey="p"><span>Printable version</span></a></li></ul>
		
	</div>
</nav>

	<nav id="p-lang" class="mw-portlet mw-portlet-lang vector-menu vector-menu-portal portal" aria-labelledby="p-lang-label" role="navigation" 
	 >
	<h3 id="p-lang-label" aria-label="" class="vector-menu-heading">
		<span class="vector-menu-heading-label">Languages</span>
	</h3>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li class="interlanguage-link interwiki-es mw-list-item"><a href="https://es.wikipedia.org/wiki/Farmacolog%C3%ADa_inversa" title="Farmacología inversa – Spanish" lang="es" hreflang="es" class="interlanguage-link-target"><span>Español</span></a></li><li class="interlanguage-link interwiki-hi mw-list-item"><a href="https://hi.wikipedia.org/wiki/%E0%A4%89%E0%A4%A4%E0%A5%8D%E0%A4%95%E0%A5%8D%E0%A4%B0%E0%A4%AE_%E0%A4%AD%E0%A5%87%E0%A4%B7%E0%A4%9C%E0%A4%97%E0%A5%81%E0%A4%A3_%E0%A4%B5%E0%A4%BF%E0%A4%9C%E0%A5%8D%E0%A4%9E%E0%A4%BE%E0%A4%A8" title="उत्क्रम भेषजगुण विज्ञान – Hindi" lang="hi" hreflang="hi" class="interlanguage-link-target"><span>हिन्दी</span></a></li><li class="interlanguage-link interwiki-ja mw-list-item"><a href="https://ja.wikipedia.org/wiki/%E9%80%86%E8%96%AC%E7%90%86%E5%AD%A6" title="逆薬理学 – Japanese" lang="ja" hreflang="ja" class="interlanguage-link-target"><span>日本語</span></a></li></ul>
		<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q7318256#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>
	</div>
</nav>

</div>

</div>
<footer id="footer" class="mw-footer" role="contentinfo" >
	<ul id="footer-info">
	<li id="footer-info-lastmod"> This page was last edited on 24 January 2022, at 16:14<span class="anonymous-show">&#160;(UTC)</span>.</li>
	<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//foundation.wikimedia.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//foundation.wikimedia.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>

	<ul id="footer-places">
	<li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy policy</a></li>
	<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
	<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
	<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
	<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Reverse_pharmacology&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
	<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
	<li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li>
	<li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Cookie_statement">Cookie statement</a></li>
</ul>

	<ul id="footer-icons" class="noprint">
	<li id="footer-copyrightico"><a href="https://wikimediafoundation.org/"><img src="/static/images/footer/wikimedia-button.png" srcset="/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation" loading="lazy" /></a></li>
	<li id="footer-poweredbyico"><a href="https://www.mediawiki.org/"><img src="/static/images/footer/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></li>
</ul>

</footer>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.704","walltime":"0.810","ppvisitednodes":{"value":3226,"limit":1000000},"postexpandincludesize":{"value":151293,"limit":2097152},"templateargumentsize":{"value":1259,"limit":2097152},"expansiondepth":{"value":12,"limit":100},"expensivefunctioncount":{"value":2,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":145178,"limit":5000000},"entityaccesscount":{"value":0,"limit":400},"timingprofile":["100.00%  630.479      1 -total"," 58.79%  370.657      1 Template:Reflist"," 41.71%  262.949     30 Template:Cite_journal"," 18.11%  114.182     16 Template:Navbox"," 14.49%   91.364      1 Template:Pharmacology"," 10.21%   64.350      1 Template:Short_description","  8.19%   51.629      1 Template:Cn","  6.90%   43.484      1 Template:Fix","  6.14%   38.681      1 Template:Pagetype","  3.98%   25.105      2 Template:Category_handler"]},"scribunto":{"limitreport-timeusage":{"value":"0.389","limit":"10.000"},"limitreport-memusage":{"value":6169554,"limit":52428800}},"cachereport":{"origin":"mw1419","timestamp":"20220201071254","ttl":1814400,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Reverse pharmacology","url":"https:\/\/en.wikipedia.org\/wiki\/Reverse_pharmacology","sameAs":"http:\/\/www.wikidata.org\/entity\/Q7318256","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q7318256","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2012-04-01T10:14:35Z","dateModified":"2022-01-24T16:14:50Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/8\/82\/Forward_and_reverse_pharmacology.jpg","headline":"drug discovery by identifying protein targets"}</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":207,"wgHostname":"mw1353"});});</script>
</body>
</html>